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Abstract
Catheter associated urinary tract infections (CAUTis) are a leading cause of morbidity and
mortality in patients with life-threatening conditions . Foley catheters are the most common
catheter used when a patient requires hospitalization but can become burdened with microbes
which lead to CAUTis, the most common source of hospital acquired infection (HAI) . The
attached bacteria can form biofilrns on the catheter which are difficult to treat using oral
antibiotics and can lead to chronic infections. Synthetic spider silk as a catheter coating shows
great promise because of demonstrated strength, biocompatibility , and antimicrobial properties .
In addition, the antiseptic chlorhexidine can enhance the antimicrobial properties of synthetic
spider silk coatings. This design project focused on creating a synthetic spider silk coated Foley
catheter that met design needs dictated by catheter usage in nursing clinical practice guidelines.
Foley catheter s were coated with 6% w/v synthetic spider silk and 6% synthetic spider silk with
chlorhexidine using five different coating protocols (spray, dip, aerosolize , dip and aerosolize ,
and spray and dip) . Catheters were tested for increased antimicrobial properties by utilizing zone
of inhibition testing . Mechanical testing included force of insertion measurements recorded on
an MTS and a bend/bunch test created by the design team . SEM and AFM images were also
taken in order to characterize the different coating methods . The final product introduces a novel
approach to catheter coatings in an attempt to combat the threat of CAUTis .
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Project Summary
Urinary and Intravenous (IV) catheters are two of the most commonly used medical devices for
administering vital drugs and obtaining diagnostic samples from patients. Unfortunately , hospital
acquired infections (HAis) occur at alarming rates due to catheter usage . The aim of this project
was to design a urinary catheter that would decrease the occurrence of these infections with a
catheter coating that utilizes the antimicrobial properties of synthetic spider silk in combination
with the antiseptic chlorhexidine . This synthetic spider silk catheter will introduce a novel
approach to catheterization in the medical industry .

l. Introduction
Intravenous catheters have been used for almost 350 years as an integral tool in patient care . IV
catheters are used in 60-90% of patients admitted to hospitals each year and introduce a potential
source of infection (Helm, 2015). Annually, 16,000 central-line associated infections occur in
intensive care units around the United States, with approximately 500 to 4000 deaths from
catheter related bloodstream infections (Mermel, 2000) . These infections are caused by the
formation of microbe colonies on the catheter and the skin surrounding the insertion site.
Advances in the catheter industry such as the Dacron cuff and antimicrobial coatings decrease
the rate of infections caused by catheterization . Most tunneled central venous catheters are
equipped with a Dacron cuff to introduce an inflammatory response that keeps the catheter in
position. It also acts as a physical barrier to microorganisms that are present on the skin.
Additional strides have been made to combat infection by investigating the use of different
catheter materials and biocompatible coatings .
Mechanical failure is another catheter problem. Peripheral venous catheters (PVCs) have failure
rates between 35-50% that are caused by phlebitis, infiltration, occlusion, and dislodgement
(Helm, 2013). Phlebitis is inflammation of a vein caused by trauma to the walls of the vessel and
is combatted by smaller-gauge catheters. Infiltration occurs when the vein is perforated by the
catheter and leads to the inadvertent administration of medications into tissue . Occlusion is a
partial or complete blockage in the catheter and can delay the administration of medications .
Dislodgement can be a result of movement and leads to other failure in the body. These problems
are addressed using different catheter gauges and mechanical improvements. The composition
and surface characteristics of catheters also contribute to failure. To alleviate this problem ,
catheters have been created out of softer , smoother , and less porous plastics such as
polyurethane.
The most common urinary catheter in use is the Foley catheter , which has similar drawbacks that
lead to catheter-associated urinary tract infection (CAUTI) . CAUTls are the most common
hospital acquired infections (HAI) and are a leading cause of morbidity and mortality in patients
with life-threatening conditions . The incidence of CAUTI is more common in females and it
increases with age and frequent disconnections. Infections occur from bacterial colonies found
on skin and are introduced into the body when the catheter is inserted (Khan, 2016) . Bacterial
6

colonies that cause CAUTis are typically different from the microbes that cause bloodstream
infections from central venous catheters.
Certain material coatings lead to increased antimicrobial activity. It is important to consider the
surface properties , antimicrobial activity, and biocompatibility when designing and testing a new
catheter , whether IV or urinary. Several different tests have been performed to evaluate surface
properties , tensile strength , antimicrobial and biocompatibility properties , and to minimize
contact with vessel walls . It is also important to ensure that the catheter can maintain these
properties during long term use within the human body .
The initial objectives of this project focused on updating current IV catheter coating methods to
implement a coating step in assembly line mass production oflV catheters . Initial mechanical
testing and standard operating procedures (SOPs) for coating catheters were created . Upon
further examination of coating methods and assembly line production oflV catheters , the project
objectives were reevaluated . New objectives focused on coating Foley catheters using three IV
catheter coating methods adapted to coat Foley catheters . These methods have been evaluated for
their roughness , friction coefficients , and antimicrobial properties . The coatings were further
evaluated for their ability to stick to the catheter when the catheter is bent in a manner to
simulate Foley catheter usage.

a. SignificanceandInnovation
Catheters have medical applications that range from peripherally inserted central venous
catheters (PICCs) , to suprapubic and indwelling urinary catheters . PICCs have a fail rate that
ranges between 30- 50%. The three most common problems that lead to their inability to be
maintained throughout the entire therapy of a patient are infections , fibrin deposition, and
thrombotic occlusion . There is research being performed to combat these fail types individuall y,
but not simultaneously. The fail time for PICCs inserted in a non-central vein is approximately
11.4 days and central veins take 16.6 days before failing (Thiagarajan , 1998) . As the time before
failing increases , a direct negative corre lation to the fail rate can be expected .
The antimicrobial properties of synthetic spider silk are widely reported. Other antimicrobial
coatings have been used to decrease the rates of HAis due to catheter usage, however , no
coatings have utilized synt hetic spider silk. This project will create novel catheters for urinary
use that have enhanced antimicrobial properties due to synthetic spider silk coatings . A
standardized protocol for various coating techniques will be developed that will allow for
uniform and consistent coating thicknesses .
As mentioned above , the original goal of the project was to modify existing intravenous catheter
coating methods to methods for mass production of synthetic spider silk coated catheters (Lewis ,
2016) . Initial testing was performed and further research showed existing methods to be
compatible with catheter production lines . Therefore, due to the lack of a design element in the
original project objectives, the decision was made to coat Foley catheters , in the hopes of
reducing CAUTI rates .
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2. Project Objectives
The aim of this project was to create a synthetic spider silk coated Foley catheter that met design
needs dictated by catheter usage in nursing clinical practice guidelines. Urinary catheters must be
inserted through the urethra , smoothly snake up through the urethra and into the bladder. The
synthetic spider silk coated Foley catheters must have a roughness comparable or better than
current Foley catheters. They must also exhibit a lower or equal insertion force . The synthetic
spider silk coating must provide an antimicrobial effect greater than that of uncoated Foley
catheters . Finally , the adhesion of the coating to the Foley catheters must be strong enough to
avoid flaking during a bend and bunch test developed by the team.

3. Evaluation Criteria
•

•

•

•

Requirements
o Measured qualitatively using Atomic Force Microscopy and Scanning Electron
Microscopy
o Exhibits either a smoother surface or equally smooth surface to uncoated catheters
Insertion Force Requirements
o Measured using MTS Instron
o Requires statistically less insertion force or insertion force equal to uncoated
catheters
Antimicrobial Requirements
o Coated catheters exhibit statistically significant larger zones of bacterial inhibition
(using three CAUTI-causing bacteria) .
Coating Adhesion Requirements during Bending/ Bunching
o When bent at various angles and when bunched, catheter coatings may crack , but
cannot flake off the catheter.

a. Design Context
A zone of inhibition test was utilized to test the antimicrobial properties of the final catheter
coatings . Antibiotic-resistant strains of bacteria, particularly methicillin-resistant Staphylococcu s
aureus (MRSA) have become a more prevalent issue in the medical field and were included in
the tests . It was proposed that the Kirby-Bauer method be used to measure the resistance of the
bacteria to the antimicrobial coating . An agar plate was uniformly streaked with the bacterium to
be tested; then , small pieces of coated catheters were placed on the surface . As the antimicrobial
diffused from the surface of the catheter , a zone around the catheter material appeared where no
growth occurred, also known as the zone of inhibition (Brown , 2015).
In addition to antimicrobial testing , a friction test method was also designed to accurately
measure the force of insertion of the coated and uncoated Foley catheters based on surface
properties . Catheters were attached to the load cell of a vertical MTS machine and inserted
through a layer of silicone material , similar in durometer to human skin . This system was able to
measure the difference in forces caused by various coatings in comparison to an uncoated Foley
catheter.
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SEM imaging was used to measure the thickness and uniformity of the coatings . Imaging also
revealed if the coating was attached firmly to the catheter or not. Samples were cut transversely
to an approximate thickness of 1 cm, secured to a mount , and placed in the machine for imaging.
AFM imaging was used to measure the roughness of the coatings . Catheters sections were cut
into strips about 8 cm long, secured to a glass slide using double-stick tape, and placed in the
machine for imaging .
Elderly male patients often have enlarged prostates, which can cause Foley catheters to bend
and/ or bunch when pushed against the prostate. Therefore , a bend and bunch test was applied to
coated catheters . This test recorded the ability of the device to conform to predetermined relevant
angles or radii. It was expected that the device would maintain acceptable mechanical properties
following the administration of the bend and bunch test. A similar torque test could have been
applied to measure these qualities as well ("Flexibility Kink Resistance," 2012) .

4. Background
a. Anatomyof CatheterUsage
Intravenous catheters are one of the most commonly utilized medical interventions for
administering medication directly into the patient's bloodstream. Intravenous catheters are a
plastic holding mechanism with a small needle extruding from them . The needle is surrounded
by a thin plastic cannula. After the catheter is inserted into a vein, the needle is removed and
discarded, and the plastic cannula is left inside the vein . The cannula is connected to external
tubing which can be used to administer medications. This process is shown in Figure 1 (Nucleus
Medical Media, 2009) .
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Proper Technique for the insertion of an
Intravenous Catheter
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catheter. Note the removal <f the
needle and the cannula that is left inside the patient's vein.

Human skin is made of three layers : the epidermis , dermis, and hypodermis. The epidermis is the
most external and is responsible for protection against harmful radiation from the sun. Below the
epidermis is the dermis, which contains nerve endings, sweat glands, hair follicles and blood
vessels. The hypodermis is a layer of adipose (fat) tissue below the dermis . The blood vessels
inside the dermis are the target for both venipunctures and intravenous catheters . Veins in this
layer tend to be more superficial and visible than arteries. Veins and arteries are also
distinguishable by palpitation. Veins are bouncy while arteries have a pulse (Netter , 2014) .
Urinary catheters are used in many patients to obtain sterile urine samples or relieve full
bladders. These catheters are inserted into the urethra and are snaked into the bladder. Once
there, urine flows out through the catheter. Foley catheters are catheters placed for long term use
and have a balloon that is inflated with saline once inside the bladder to hold the catheter in
place . Male and female urinary catheters are different due to anatomical differences . Men have
much longer urethras and must have longer catheters . The male prostate can also complicate

catheterization . As men age, their prostates enlarge and cause the urethra to contract. As a result,
catheters with a rigid tip, called Coude catheters , must be used to force a way through the
prostate . Figure 2 shows the anatomy of the male prostate . The female urethra is much harder to
locate which can cause difficulties in catheter insertion (Netter , 2014) . Figure 3 shows the
comparison between a female and male urinary catheter (Duyao, 2015 ).

--1+
-= '-.:-f-f--.:r'-'.-;1-+-f--t--Prostatc
gland

Figure] : An enlar[.;edprostate can require the use ~la Coude catheter in male patients .

Figure 3: f'he d[ffaences between a male (lej!) and.female (right) catheter are shown. Note the
longer catheter used in the male patient.
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b. Current Issues
Hospital acquired infections (HAls) are a leading concern among the global medical community.
Approximately 800,000 patients each year in the United States are introduced to an infection
while in hospital care . These infections cost the medical industry an estimated $4 billion
annually . Critically ill patients in intensive care units have the greatest risk for contracting an
infection due to increased exposure compared to other areas of the hospital and weakened
immune systems. The most common HAis are urinary tract infections (UTis) , pneumonia , and
primary bloodstream infections . Approximately 64% of HAis are caused by gram-positive
bacteria , 27% are caused by gram-negati ve bacteria , and 8% are caused by fungi (Edmond ,
1999). Necessary medical devices such as catheters are one of the leading mechanisms for these
infections to occur . Many HAis are a result of drug resistant strains of bacteria such as
methicillin-resistant Staphylococcus aureus (S. aureus) (Edmond, 1999).
Medications are administered to patients in three primary ways : orally , intramuscularly , or
intravenously . Medications given orally are absorbed through the digestive system and into the
bloodstream , usually by either the stomach (as in the case of nonsteroidal anti-inflammatory
drugs) or the small intestine (as in the case of acetaminophen) . Though these medications last
much longer than medications given through other administration methods , they do not act
quickly. Medications such as norepinephrine , which is used to raise blood pressure in cardiac
arrest patients , or haloperidol , which is used to sedate violent patients, must act immediately.
Intravenous medications such as these are injected directly into the bloodstream, meaning they
act much quicker. However, as a result, they do not last nearly as long . Some medications are
harmful to the inner linings of veins and cannot be given intravenously . Because of the damage
they cause when administered intravenously , they are given intramuscularly . This allows for a
faster route to the bloodstream than oral medications, but it doesn't damage veins (Spencer &
Gilliam , 2015; Vacca , 2013) .
PVCs are the most common tools used to administer drugs directly to the bloodstream. These are
inserted into a small vein, usually located on an extremity, and are used in 60-90% of patients
admitted to United States hospitals. Based on the age of the patient, the size of available veins,
and the medication that must be given, different sizes of PVCs can be used . 22 or 24 gauge
catheters are generally used for pediatric patients. Adult patients receiving medications such as
vancomycin require 18 gauge or larger PVCs . PVC failure rates vary between 35-50% , and occur
in the form of phlebitis , infiltration , occlusion , dislodgment , and infection (Helm , 2015) .
Phlebitis is the inflammation of a vein caused by trauma to the walls of the vessel. There are two
types of phlebitis : superficial phlebitis and deep vein thrombophlebitis (DVT) . Insertion of PVCs
can cause superficial phlebitis which is usually not harmful to the patient . However , they can
increase the chances of an HAI , which can cost thousands of dollars in treatment per case . Even
in cases where phlebitis does not cause infection , it can require extra treatment , raising the costs
of hospital stays (Feldman , 2004) . Phlebitis risk factors include inactivity , which explains why
most of phlebitis cases occur in intensive care units . These patients are usually bed-ridden for
most of their stay. Phlebitis is treated by pain control , elevation, and warm compresses , provided
it is discovered early. However , delayed detection of superficial phlebitis can lead to infections ,
12

as discussed above (Tintinalli , 2016). An image of phlebitis is shown in Figure 4 (Smeltzer,
2010) .

Figure -I: Phlehit;.,· in a patient. Note the e1ythema (rednes.s) s111-row1dingthe catheter insertion
site.

Infiltration occurs when the PVC is placed improperly or dislodges and perforates the side of the
vein. This causes medications given through that catheter to leak into the surrounding tissue.
This can lead to tissue damage, infection , necrosis of the tissue , and amputation. When a PVC is
inserted , it is flushed with approximately l 0 mL saline to ensure that the catheter is inside the
vein. If it has infiltrated , the saline will flush into the surrounding tissue , causing a visible bump ,
and the catheter will be removed . Infiltration can also occur due to patient movement. This can
be much harder for a provider to notice until new medication is given (Feldman, 2004). A
diagram of infiltration is shown in Figure 5 (Smeltzer, 2010) .

Figure 5: ft?filtratio11~fa vein. ff medications were administered they 11'011/d
leak into tissue
surrounding the vessel.
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As mentioned above, certain medications are harmful to the inner lining of veins. If medications
such as those used for chemotherapy leak into surrounding tissue , they can damage the tissue as
well as the surrounding blood vessels (Robl , 2016). Infiltration is the inadvertent administration
of non-vesicant drugs , or drugs that do not damage the tissue they come into contact with . In
contrast , extravasation is the inadvertent administration of vesicant drugs and can lead to tissue
necrosis and potential amputation (Feldman , 2004) . Risk factors for PVC infiltration include
diabetes , hypertension , dehydration , and local trauma due to frequent PVC insertio n or IV drug
use . Conditions such as diabetes , hypertension , and dehydration cause the walls of veins to thin
and therefore lose structural integrity . Local trauma causes scarring and makes it harder for the
healthcare provider to insert the PVC correctly and can weaken the walls of veins. Infiltration
can be treated by either cold or warm compresses to either limit exposure to tissue or stimulate
blood flow to dilute the medication (Kagel , 2004) .
Occlusion occurs when the catheter is obstructed in some way . Hard , or complete occlusions ,
occur when the obstruction completely blocks the pathway of medications . Soft occlusions occur
when the pathway for medications is only partially blocked. The former is far more dangerous
because they cause an increase in pressure in the catheter line and cause the vein with the PVC to
collapse. Furthermore , occlusions can delay the administration of vital medications (Scott , 1996).
A diagram showing the difference between hard and soft occlusions is shown in Figure 6
(Genetech , 2017) .

Figure 6: A .w?ftocclusion (leji) partially b/ocksfluidflow
completely blocks.fluidfloH'.

while a hard occlusion (right)

The main concern with any medical procedure is infection . Hospitals are constantly attempting to
lower the rates ofHAls , and PVCs can cause bloodstream infections . HAis cost hospitals nearly
$10 billion annually and they increase the length of stay for patients. Hospital acquired
bloodstream infection rates range from 1.3 to 14.5 infections per 1000 hospital admissions .
Every year 62,500 people die of these infections (Zimlichman , 2013 ; Heister , 2017) .
In the past, bloodstream infections originated from gram-negative rods. However , the rate of
bloodstream infections caused by gram-positive cocci has surpassed the rate of infections caused
by gram-negative rods . This is thought to be a result of the increased use of intravenous
catheters . For example , at least one third of all S. aureus (gram-positive coccus) infections
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caused in a hospital are a result of intravenous catheters. An infection from S. aureus can lead to
complications such as MRSA , which typically requires 4 to 6 weeks of daily IV therapy (Meier ,
1998) .
Patients who are paralyzed, temporarily bedridden, or patients who have had epidurals do not
have the ability to urinate normally . Depending on the situation , medical professionals use either
short-term or indwelling urinary catheters . Concerns with urinary catheter usage include patient
sex, type of urinary catheter , blood clotting in and around the catheter , and infection . When using
a catheter, a larger lumen diameter catheter is used for male patients , a smaller lumen is used for
female patients , and the smallest diameter is used for infants. Because male urethras are much
larger than female and infant urethras, catheters used for male patients must have larger lumen
diameters (Stephens , 2017) .
There are two main types of urinary catheters : quick-caths and Foley catheters. Quick-caths are
catheters inserted into the bladder to collect a urine sample or empty a bladder and are
immediately removed . The main issue associated with these catheters is insertion trauma ,
especially in male patients. However, significant long-term effects of quick-caths are minimal
(Fink, 2012) . Foley catheters come in two styles depending on the intended dwell time . Regular
Foley catheters are intended for shorter dwell times while patients requiring catheters for long
term use utilize silver-coated urinary catheters . The antimicrobial properties of silver are useful
because infection rates increase as dwell time increases (Hashmi , 2003 ). Guidelines for dwell
times requiring silver-coated urinary catheters are facility-dependent.

Foley catheters are far more common and come in various lumen diameters , measured on the
French scale . The diameter in millimeters is equivalent to the French measurement divided by 3.
However , many elderly male patients have enlarged prostates . This causes resistance in the
insertion process. Healthcare workers can use Coude catheters which have a stiff tip to help push
the catheter through any inflamed prostate tissue . These types of catheters cause more pain and
are therefore used less frequently than Foley catheters (Stephens , 2017) .
Another concern with enlarged prostates is the possibility of blood clots forming in and around
the catheter. When this happens , catheters must be irrigated and flushed . Blood clots form when
blood encounters a surface , such as a catheter , and initiates the intrinsic pathway of the
coagulation cascade , forming a clot that occludes the catheter (Ratner, 2013) .
The primary concern with any urinary catheter is a urinary tract infection (UTI) . 95% of UTis in
critical care patients are a result of urinary catheter usage and are caused by a variety of different
organisms (Rupp , 2004) . Catheter-associated urinary tract infections (CAUTls) are one of the
most common HAis that patients receive during their hospital stays (Rupp , 2004). CAUTls
contracted in the first few days of catheter use are caused by Staphylococcus epidermidis (S.
epidermidis) , Enterococcusfaecalis , and Es·cherichia coli . However , as dwell times increase ,
CAUTis can also be caused by Proteus mirahilis and Pseudomonas aeruginosa (Stickler &
Sabbuna , 2007) .
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CAUTTs follow a specific progression. Bacteria attach to the uneven surfaces of catheters which
contain microscopic imperfections (Stickler, 2003). Bacteria can attach either intraluminally
(inside the catheter) or extralurninally (outside the catheter between the urinary tract and the
catheter) (Garcia , 1999; Tambyah , 2004). The bacteria then form an antibiotic resistant biofilrn
which harbors , nurtures , and protects bacterial growth on the catheter. These biofilms infect the
bladder (Kurnon et al., 2001 ; Cormio et al., 2001; Burton et al., 2006 ; Trautner & Darouiche,
2004; Helm , 2015) .

c. CurrentAnti1nicrobialSolutions
Antibiotic resistance is a major concern in today ' s medical community . Over the course of the
past several years , antibiotics have not improved and diseases such as MRSA and other
"superbugs " are on the rise. Approximately 70% of infections that happen while a patient is in
the hospital are bacterial infections that are resistant to at least one traditional antibiotic used for
treatment. They are hard to combat without providing a "cocktail " of antibiotics which leads to
antibiotic resistance (Lara , 2009) .
The source of most catheter-related bloodstream infections occurs in catheter hubs and the skin
surrounding the insertion site. Therefore, most research is focused toward preventing bacterial
colonization at these locations to keep the bacteria from spreading into the bloodstream and
creating a biofilm on the surface of the catheter.
UTis are the most common hospital acquired infection in patients who are in intensive care units
(ICUs) . The infection can travel up the urinary tract and into the kidneys which causes
inflammation . If the pathogenic organism reaches the bloodstream , the patient can become septic
(infected) . Catheters account for more than 40% of cases of sepsis in acute-care hospitals
(Samuel , 2004 ).

i. Metal Coatings
Various metals exhibit antimicrobial properties . Silver is the most popular metal for catheter
coating because it combines high antimicrobial activity with low human toxicity (Schierholz,
1998). Since the 19th century, silver compounds have been used in a variety of antibacterial
solutions . The properties of silver as a medical compound have been recognized for about 2,000
years (Prabhu , 2012) .
Unfortunatel y, there are drawbacks to this approach The manufacturing costs of these catheters
are very high . A silver alloy-coated catheter costs $13 compared to $7 for a standard catheter
(Saint , 1998). Silver can affect patients differently based on gender because men and women
develop CAUTis differently . The catheters are more effective at preventing infection with gramnegative rods (most common infection in women) than gram-positive cocci (most common
infection in men) . For this reason, women benefit from the silver-coated catheters more than men
(Saint, 1998). Metals may also leach poison into the patient's body . A product under United
States patent US5520664A seeks to solve this issue by embedding silver into a catheter to ensure
that the atoms of the antimicrobial metal are substantially non-leaching .

16

ii. Antibiotics and Antiseptics
Antibiotics such as vancomycin have been shown to reduce the risk of catheter-related
bloodstream infections . Centers for Disease Control and Prevention guidelines recommend
against prophylactic use of vancomycin because it is an independent risk factor for acquisition of
vancomycin-resistant enterococci (Mermel, 2000) . It has been suggested that additional
antibiotics such as minocycline and rifampin be used to avoid systematic use of a single
antibiotic . However, antibiotic coatings are more expensive and can lead to antibiotic resistance
(Kusek, 2012 ; Samuel, 2004) . Therefore, solutions should be focused on interventions that will
not encourage the emergence of such resistance.
Antiseptic coatings also show antimicrobial effectiveness . The cuff of the catheter , known as the
Dacron cuff, is an important site for this type of coating because it is tunneled into the patient's
skin to provide a tissue-interference barrier. The Dacron cuff is used to introduce an
inflammatory response within the tissue . The response acts as a barrier to microorganisms and
helps prevent dislodging of the catheter . Short-term use catheters that are coated with antiseptics ,
such as chlorhexidine and silver sulfadiazine, reduce the risk of central venous infections . Not
only do these methods decrease the risk for infection but also reduce the cost per catheter .
Antimicrobial activity of the catheter decreases over time so antiseptic coatings should only be
used for short-term catheters that are in use for less than two weeks (Mermel, 2000) .

iii. Nanoparticles
Nanoparticles are also a field of interest because of their ability to create a smooth surface that is
non-toxic to the human body . Nanoparticles are nanornaterials that measure less than 100
nanometers in at least one direction . Commonly researched nanoparticles include copper II
oxide, silver, gold, and zinc oxide . The addition of nanoparticles into a known antibiotic
enhances the bactericidal effects of the antibiotic (Lara, 2009) . Silver shows the most promise in
combating infections and antibiotic resistance (Kirn, 1994). Silver nanoparticles inhibit the
activities of interferon gamma and tumor necrosis factor alpha which are biomarkers of
inflammation (Prabhu, 2012) .
United States patent US 8647675B2 describes a silver nanoparticle antimicrobial coating for
implantable medical devices that can be used for long-term and short-term infection resistance .
The coating consists of three distinct layers of silver nanoparticles of different sizes that extend
over the surface . A Chinese patent CN 102380130 specifically describes the coating of a
modified polyurethane central venous catheter with silver nanoparticles . The process consists of
immersion of the catheter in a mixed solvent of ethanol and deionized water before being
immersed in a silver nitrate solution by UV irradiation . Nanotechnology is a promising coating
mechanism. A thin coating of nanoparticles , approximately 100 nanometers thick, slowly
releases silver ions over the course of several days (Roe, 2008). Due to their large surface area,
they are more effective. The silver ions bind to the cell wall of the bacteria and, due to their
toxicity , cannot be removed (Prabhu, 2012) .
Despite showing a reduced risk of infection, nanoparticles in central venous catheters (CV Cs)
can cause catheter-associated thrombosis in critically ill patients (Stevens, 2009). Nearly 54% of
patients in ICUs have a CVC which are associated with an infection rate of 5 per 1000 catheter
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days. In critically ill patients, approximately 87% of blood infections are a result of CVC use
(Raad, 20 l 1). Primary blood infections from CV Cs are caused by various strains of
Streptococcus , Staphylococcus, Enterococcus , and Candida (Stevens , 2009). Streptococcus
bacteria cause approximately 36% of blood infections that arise from CV Cs (Richards, I 999) . In
the United States, approximately 3 million CVCs are inserted each year. Approximately 850,000
of CV Cs inserted result in an infection, of which 20% are serious and 28% are fatal (Furno ,
2004) .
Despite the strong antimicrobial properties of silver nanoparticles , these can affect the
biocompatibility of blood (Stevens , 2009). However, exposure to metallic nanoparticles over a
ten-day period does not pose a toxic risk to the patient. In addition , silver nanoparticles applied
to an intravenous catheter continue to release silver ions that inhibit bacterial infections over a
ten-day period (Roe, 2008) . There is no change in silver concentration over 370 days in urinary
catheters and no dangerous levels of silver reach the bloodstream (Samuel , 2004). Silver
nanoparticles are a much more viable solution to reduce the risk of infection in urinary catheters
compared to broad-spectrum antibiotics.
To ensure biocompatibility , nanoparticles must be biologically synthesized . Chemically
synthesized nanoparticles are toxic to humans . If they enter the bloodstream the particles can
easily enter the blood-brain barrier. Certain strains of bacteria, plants, and fungi can synthesize
silver nanoparticles . Plant extracts are nontoxic, cheaper , and synthesize nanoparticles quickly,
and can be used to synthesize nanoparticles for biological use (Prabhu , 2012).

d. OtherCurrentSolutions
Many patented catheter modifications are intended for reducing pathogens entering the body and
causing infection. The products often focus on elimination of the rough catheter surface using a
coating . Plastic catheters and various coatings exhibit a smoother surface that improves
performance and lowers failure rates. Catheter research focuses on preventing infections , fibrin
buildup, and thrombosis (blood clots) . Several of these techniques can be combined to further
reduce the .chance of complications from catheter use.

i. Preventing Infections
Improvement of techniques for insertion is centered primarily on proper training and
preventative measures such as avoidance strategies, hand hygiene , and daily catheter checks.
Proper intervention techniques combat CAUTis which can be caused by improper insertion
techniques. It is important for improvements to occur to increase patient health and decrease
costs for hospitals and other healthcare institutions . Direct observation decreases healthcare costs
and patient safety, but the most successful strategy to fight CAUTI is to decrease the use of
indwelling catheters (Galiczewski , 2017). Due to the necessity of urinary catheters , there is a
demand for an improved product.
The use of silicon coated catheters has also been studied as a solution to CAUTis . Unfortunately ,
there are no statistically significant data that reveal an advantage to using silicon as a catheter
coating (Stenzelius , 2016). Antimicrobial coatings based on antimicrobial peptides are also
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suspected to combat CAUTis. A polyurethane catheter coated with an anti-adhesive hydrophilic
polymer coating and antimicrobial peptides prevented bacterial adhesion and inhibited
planktonic bacterial growth. These results provide a significant start to understanding the
benefits of non-metallic and non-antibiotic coatings for urinary catheters (Yu, 2017).

ii. Preventing Fibrin Buildup and Thrombosis
Fibrin is an important protein that is involved in blood clotting . It forms a fibrous mesh that ,
together with platelets from the blood stream, impedes blood flow . Fibrin is activated in the final
stage of the coagulation cascade , which can be initiated by the presence of foreign substances
like catheters. Fibrin adhesion to these surfaces can lead to thrombosis . Fibrin deposits have been
shown to increase bacterial colonization of S. aureus (Vanassche , 2013) . Antibodies have been
developed to prevent the adhesion of S. aureus to fibronectin, but the simplest solution for this
problem is catheter replacement (Sun, 1997). Current protocols suggest that intravenous
catheters should be changed at least every 3 days, and urinary catheters should be changed at
least every 7 days, though daily inspection of the catheter is necessary (Kusek , 2012).
Systematic application of heparin, a blood thinner, prevents fibrin deposition . Intravenous
catheters coated with heparin delay fibrin deposition on the outside of catheters (Amplatz , 1971).
Heparin medication can be administered during short-term intravenous catheter use but must be
administered twice a day and requires constant monitoring to prevent thrombocytopenia (low
blood platelet count). Patients with PICC lines must be put on blood thinners such as Prophylaxis
with low-dose Coumadin to reduce the risk of thrombosis (Mermel, 2000) . Both solutions are
effective, but require great care on the part of healthcare professionals . Though catheter
replacement reduces the risk of catheter failure and fibrin buildup , it can also increase the risk of
infection . Clot formation occurs in both intravenous and urinary catheters , though there are no
universally accepted solutions to prevent clot formation with urinary catheter use.

iii. Ease oflnsertion Solutions
Progress has been made in catheter technology due to new polymers that combine lubricity ,
softness, and bunch resistance . In addition, the texture and shape of the catheter tip could also
play a role in reducing infiltration . Some of the most common strategies to increase ease of
insertion include the use of specialized personnel , bevel-down needle insertion in small vessels,
the use of local anesthetics , and topical visualization agents. Imaging techniques which assist in
vein visualization are also being developed (Helm, 2015) .
Ultrasound-guided cannulation (insertion of a thin tube) of deep mid-arm veins by a modified
Seldinger technique (US-Seldinger) yields better puncture success rates and lower postoperative
complication rates . The technique includes features such as application of pressure with gauze ,
skin stretching , and immediate delivery of the catheter upon insertion of the catheter sheath.
When an ultrasound is used in conjunction with the Seldinger technique , the operator can obtain
a clear image of blood vessels which makes it easier to choose an ideal vein for catheter
insertion . For this reason , ultrasound guidance provides more precise targeting for needle
puncture. The use of the Seldinger technique was also proven to reduce bleeding , pain,
complications , and discomfort . Ultrasound equipment used in association with US-Seldinger for
a single catheterization operation cost more than the traditional non-US trans-cannula PICC
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insertion method , but it has a reduced complication rate . It was concluded that the US-Seldinger
technique improves catheter insertion and is suitable for clinical application (Tan, 2016).
The site of insertion has been considered in the fight against pathogens. Insertion of a catheter
into the subclavian vein reduces the risk of infection when compared to insertion into the internal
jugular vein. Subcutaneous tunneling is an additional catheter insertion technique . According to
US patent US4832687 , two remote incisions are made and the patented subcutaneous tunneling
instrument and method are used to tunnel from one incision to the other . The catheter can then be
inserted into the body. However , this technique should not be used if the catheter is intended to
draw blood (Mermel , 2000) .
Urinary catheters are one of the most uncomfortable medical procedures for patients. As such,
many ideas have been implemented to ease the insertion of these devices . The use oflubricant is
the primary method used to reduce friction . However , silicone coatings , proper patient
compliance , and the use of the smallest possible catheter can also help to make the experience
more comfo1iable for patients (Fink, 2012) .
Lubricant helps to minimize the friction between the urethral wall and the catheter. Though its
use is vital, often , the lubricant only helps for the first 5 cm of insertion . After that point, the
lubricant rubs off Catheters can be coated in silicone to also minimize the friction force during
insertion.
Another factor in patient comfort is their own compliance. The most important factor patients
can control is the tension in their muscles. A tense patient will experience more pain. Another
nursing technique to ease the insertion of a urinary catheter in a female patient is to position the
patient lying flat on their back, with their knees bent. This allows the healthcare provider easy
access to the urethra and avoids any unnecessary bending or bunching in the catheter as it is
being inse1ied. In male patients , healthcare providers instruct the patient to lie flat on their back
with their legs straight. The key to avoiding unnecessary bending or bunching during catheter
insertion in male patients is to hold the penis perpendicular to the body . This position places the
urethra in a straighter position , allowing for easier catheter insertion (Fink, 2012).

e. CurrentSpiderSilk Technology
Synthetic spider silk is a tough fibrous material with high bond energy and strength comparable
to Kevlar. This biomaterial has biocompatible protein fibers and tunable mechanical properties.
The spider in study, Nephi/a clavipes, produces six different types of silk that have unique
qualities and purposes for the spider. Harvesting silk from the spiders in large quantities is
difficult because they are territorial and cannibalistic . Largescale production of synthetic spider
silk has been studied through recombinant protein production.
Although all six of the proteins have been sequenced , there are varying levels of research for
each one. The Dragline silk is the strongest , while the Flagelliform has the greatest strain-tobreak ; these silks are the most understood and studied . Beta-sheet secondary structures are
common , highly repetitive motifs found in each of these proteins. These structures create a high
crystallinity and play an integral part in the strength of the fibers which, when combined with
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other alpha-helices, contribute to the extendibility (Guerette, 2014) . These protein structures
allow researchers to develop custom proteins that include many of the motifs common in the
sequenced Dragline and chimera proteins. Recombinant proteins created for the Dragline silk,
namely MaSPl and MaSp2, are the only proteins that have been expressed in and harvested from
goat milk (Hinman, 2000). This is significant as there is limited scalability available in using
goat-derived spider silk proteins . Most spider-silk proteins are goat-derived and any major
applications will require recombinant proteins scaled in E. coli.
Synthetic spider silk has shown promising results for many medical applications as it does not
elicit an immune response, allowing the silk and its products to integrate with tissue . No
significant immune response is observed from implanted silk in rats which shows promise for
human trials. Synthetic spider silk has also shown improved results in wound closure
applications (Hayashi, 1999) . Fibroblasts, osteocytes, and mammalian cells can grow on natural
spider silk fibers , synthetic spider silk films, and silk hydrogels (Brooks , 2005). Modified silk
structures can increase cell proliferation and attachment. Other complementary structures of the
synthetic spider silk proteins such as hydrogels , glues , and coatings show promising results in
biocompatibility with tunable degradation. Silk films show potential in vaccine storage systems
because of decreased bioactivity of the vaccines . Furthermore, silk films can store vaccines at a
higher temperature which indicates that a less expensive and stringent storage requirement could
be possible (Rieke! , 2000).
Synthetic silk production is significantly different from natural fiber production . A spider forms
silk protein in individual glands at concentrations of 30-45% weight to volume (w/v) which feed
through spinnerets. These proteins are then pulled into a fiber by the back leg of the spider. The
protein is secreted and stored in the gland as an aqueous solution and is transformed into a solid
fiber as it travels through a fine duct. Synthetic fiber resists solubilizing in water and many other
organic solvents. The high concentration found in spider glands has not yet been created in a
laboratory setting . When solubilized in hexaflourophosphoric acid, synthetic spider silk reaches
concentrations of 12-17% weight to volume .
Aqueous solutions of synthetic spider silk proteins yield lesser concentration . However, the
absence of harsh organic solvents increases safety, cost effectiveness, and decreases the
environmental impact. Aqueous based synthetic spider silk proteins have been investigated for
use as adhesives and coatings . Silk protein based coatings can adhere to numerous substrates
(Harris , 2016) . Silk materials also possess a smooth surface that does not interfere with blood
flow which helps to decrease these inflammatory responses (Hess, 2001). Due to the
recombinant nature of the protein and their capability to include other solutes, these coatings can
be functionalized for a range of applications . These include prevention of blood clotting and
biofouling. This is accomplished by forming drug-eluting coatings that release compounds such
as heparin or antibiotics to improve the longevity of intravenous catheters .
There are currently no patents for catheters that incorporates synthetic spider silk technology .
However , it is being investigated for other medical applications and a synthetic spider silk
coating has been approved for stents. A World Intellectual Property Organization patent WO
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200103 83 73 claims the creation of an improved implantable stent-graft prosthesis to minimize
tissue inflammatory responses .

5. Design Process
a. ProjectOverview
Catheter-related infections are currently combatted using different catheter materials , metal
catheter coatings, and antibiotic catheter coatings . The purpose of this project was to create a
urinary catheter with antimicrobial properties by introducing a synthetic spider silk protein
coating . In this experimental design , a standardized method for uniform synthetic spider silk
protein coating has been developed to provide accurate results for all subsequent testing . To
produce a product comparable or superior to current catheters in use, specific evaluation criteria
were satisfied . AFM and SEM imaging were used to study the roughness of the synthetic spider
silk coated catheter and uncoated catheters . The insertion forces of the coated catheters were
measured using a vertical MTS to introduce the devices through a layer of silicone material with
similar durometer to human skin. Additionally , the antimicrobial properties of the catheter were
confirmed using zone of inhibition testing , and the adhesion of the coating to the catheter was
observed using a bend and bunch test. A summary of the design decisions made is shown in
Figure 7.
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b. Design Steps
i. IV Catheters vs. Urinary Foley Catheters
The first major decision made in this project was deciding to pursue the coating ofIV catheters
or urinary catheters . At first , IV catheter coatings were pursued . Though synthetic spider silk
coatings had been used for IV cathete rs in the past , the effect of thickness on these coatings had
not been explored. The goal of the project would have been to design a method capable of being
upscaled to mass production levels . However , faculty advisor Dr. Randolph Lewis clarified that
coating thicknesses have little effect on antimicrobial properties . After exploring the catheter
coating process previously studied , upscaling to mass manufacturing levels would not require
any major design decisions.
Synthetic spider silk coatings for urinary catheters have not been previously investigated. Due to
the increasing rate of CAUTI infections and the healthcare industry's prioritization on lowering
CAUTI rates , catheter manufacturers are highly interested in antimicrobial coatings. Foley
catheters were coated instead of Coude catheters due to the lack of a hardened tip which
simplified the coating process . A summary of the benefits of coating urinary catheters are shown
in Table 1.

Table J: Summa,y <!/"decisionsto coat urinary catheters O\'eri11tra1
e11ouscatheters.
1

Catheter
Type

Pros

Cons

Urinary

Cheaper
Many design decisions
Easier Imaging

Requires more spider silk
No established methods

Intravenous

Method Established

Minimal Designing Involved
Difficult to image
More difficult to coat

ii. Synthetic Spider Silk Solution Optimization
Prior to antimicrobial testing with the final catheter samples , initial testing was performed to
assess the effect of synthetic spider silk and chlorhexidine , an antiseptic commonly used in
medical applications, against three common sources of CAUTis : E. coli, S. aureus, and S.
marcescens . Since chlorhexidine had never been used as part of a coating method it was
imperative to know whether it would be beneficial to include as part of the final methods .
Mc1terials
• Liquid Luria-Bertani (LB) media
• Solid LB media with 2% Agar
• Petri dishes
• Sterile Cotton Swabs
• Medical grade silicone
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Methods ·
A 6% synthetic spider silk solution was prepared according to protocol in Appendix a. Medical
grade silicone was cut into disks ten millimeters in diameter before sanitization with 70%
ethanol. The disks were coated using one of three options : synthetic spider silk, synthetic spider
silk+ ] .5% chlorhexidine , or 20% chlorhexidine . As a negative control , several disks were left
uncoated . Chlorhexidine swabs that are used in hospitals contain 2% chlorhexidine . For the
second round of trials, the chlorhexidine was diluted from 20% to 1.5%. The 1.5% chlorhexidine
was chosen after examining data from prior trials performed by the faculty mentor , Dr. Lewis .
These trials showed that a 1-2% chlorhexidine solution is ideal. Each disk was dipped in the
correct solution for three seconds before it was placed on a paper towel to dry. The disks
received the appropriate coating method three times. Once the three coatings were completed,
the disks were allowed to dry completely. Agar plates were prepared according to the recipe in
Appendix a and streaked with E. coli, S. marcescens , S. aureus . Three plates were streaked for
each bacteria species . One plate was the control which contained only the target bacteria . The
additional two plates each had four disks containing an uncoated disk and a disk with each of the
above coating methods . The plates were incubated inverted at 37° C for 24 hours before zone of
inhibition measurements were taken .
Several issues were observed when the plates were checked on the first day. The bacteria were
not streaked effectively (the bacteria appeared in grids instead oflawns) and a few of the
uncoated silicone disks had moved from the designated grid. An inoculation needle had been
used to spread the bacteria on the plates and the needle had gouged the agar in several locations .
The results from the first day are shown in Figure 8. It was decided that the initial antimicrobial
testing needed to be repeated to resolve the errors that arose.
To ensure proper salvation of synthetic spider silk protein in solution, three mL of the 6%
synthetic spider silk solution was prepared for the second round of initial antimicrobial trials
instead of two mL. Bacteria were inoculated for 48 hours at 37° C in LB broth instead of agar
slants so that cotton swabs could be used to streak the plates in order to form confluent bacterial
lawns . Once again, the disks were dipped a total of three times . The same three bacteria (E. coli,
S. marcescen s, S. aureus) were used for the trials . Inspection of the plates upon the first day of
measurements showed the desired bacterial lawn . The zone of inhibition that was measured on
the first day was marked with a Sharpie to report a consistent measurement each day.
Measurement s were recorded every 24 hours for a total of 7 days.

Results
Results from the last day of measurements are shown in Figure 9. All pictures and data are
shown in Appendix b. Note that the diameter of the zone measured on the first day are marked
with a Sharpie in order to keep measurements consistent. Statistical analysis of antimicrobial
data is shown in Tables 2, 3, and 4. Statistical analysis was run using GraphPad Prism using
column statistics and one-way analysis of variance (ANOVA) with Tukey HSD post-hoc test.
Significance when compared to the uncoated control has a p-value less than 0.05.
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Figure 8: Picture of plates cifter the.first day qfzone c~finhibition measuremems. (1) h·om top to
bottom: S. marcescens colllrol plate, S. marcescens replicate plate one, S marcescens replicate
plate two. (2) From lop lo hu/10111:S. aureus comrul plate, S. aureus replicate plate 011!!, S.
aureus replimle plate two. (3) From top to bollom: E. coli control plate, E. coli replicate plate
one, E. coli replicate plate two. On all replicate platf!s starlingj1'0/11the lop le.ftand mol'i11g
clockwise: uncoated disk, synthetic .\pider silk coated disk, ·')'lllhetic .\]Jidersilk · 1.5%
chlorhexidine disk, and 1.5% chlorhexidine disk. Note that sel'eral disks mowdfrom the
designated quadrant.
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Figure Y: Picture ofplates after the sevemh dc~vqfzone of inhibition measure men ls. (1) From
top to bottom: E. coli control plate, E. coli replicate plate one, E. coli replicate plate two. (2)
hmn top to bottom: S. aureus control plate, S. aureus replicate plate one, S. aureus replicate
plate two. (3) h·om top to bottom : S. marcescens control plate , S. marcescens replicate plate
one, S. marcescens replicate plate t11•0. On all replicate plates starting.from the top le.ft and
moving clockwise : uncoated disk, .\ynthetic .spider silk coated disk, .synlhetic .spider silk , 1.5%
chlorhexidine disk, and 1.5% chlorhexidine disk.
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fohle ] : Statistical analysis.for the disks using the se11enthdc~yzone(?( inhihitiun measurements
for E.coli .
Stardard
Error of tl'C
Avemge(mm)
Mean

Lower95%
Upper95%
Stardard
Confidence
Confidence
Deviation lnte1v·JlofMean lntervaJof Mean

Significant
Conipared to
Uocoated

Uocoated

10.00

0.00

0.00

10.00

10.00

No

SyntheticSpider Silk
SyntheticSpider Silk+
Chlorlx:xidire

12.75

0.75

1.06

3.22

22.28

Yes

18.00

0.00

000

18.00

18.00

Yes

Chlorlcxidiic

17.50

0.50

0.71

ll.15

23.85

Yes

J'able 3: 5'tatistica/ ana(rsisfor the disks 11si11g
the seventh day ::one (?{inhibition measurements
for S aureus.
Stardard
Error oftlc
Avernge(nm1)
Mean

Lower95%
Upper95%
Confidence
Starrlard
Confidence
Deviation lntervaJof Mean IntervaJof Mean

Significant
Compared to
Urcoated

Urx::oated

10.00

0.00

0.00

10.00

10.00

No

SyntheticSpider Silk
SyntheticSpider Silk +
Chlorlcxidine

14.50

0.50

0.71

8.15

20.85

No

28.50

5.50

7.78

-41.38

98.38

No

Chlorhexidine

32.00

6.00

8.49

-44.24

108.20

Yes

Table ./: Statistical analysis.for the disks using the sel'enth day zone
for S. marcescens.
Stardard
Error of the
Average (mm)
Mean

ql inhibition measure me Ills

Significant
Lower 95%
Upper 95%
Stardard
ConfKience
Confidence
ConJ>aredto
Uncoated
Deviation fntervalofMean IntervalofMe~m

Urx::oated

10.00

0.00

0.00

10.00

10.00

No

SyntheticSpider Silk
SyntheticSpider Silk +
Chlorlcxidirc

12.00

LOO

1.41

-0.71

24.71

No

2000

1.00

1.41

7.29

32.71

No

Chlorlcxidirc

21.50

4.50

6.36

-35.68

78.68

No

Conclusions

It was decided that sterile cotton swabs needed to be used in all further experiments to create the
bacterial lawn due to the grid-like appearance shown in Figure 8. Figure 9 shows the confluent
lawns that were created when using the cotton swab. The disks that were coated with
chlorhexidine showed successful zones of inhibition and were included in the final catheter
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coatings . Chlorhexidine was shown to enhance the antimicrobial properties of the coating
solution and was later used in trials with Foley catheters.

iii. Catheter Coating
To test the mechanical and antimicrobial properties of the coated catheters, coating methods had
to be optimized. Previous results in literature suggested methods such as dip and spray coating
(Lewis, 2016). Based on suggestions from the faculty mentor and industry representatives, an
aerosolize coating was developed along with coatings combining methods . Based on the
qualitative results from synthetic spider silk solution optimization, coatings were made using
synthetic spider silk and synthetic spider silk with 1.5% chlorhexidine solution .
1. Dip Coating

Materials
•
•
•
•
•
•
•
•
•
•

Polycarbonate (thickness of 0.6 cm)
Loctite Plastic Epoxy
Loctite Super Glue (Cyanoacrylate)
6% w/v Synthetic Spider Silk Solution
20% Chlorhexidine Solution
Latex Urinary Catheters
Stren Super Knot Monofilament Fishing Line
Dritz Yarn Darners
10% Bleach Solution
20% isopropyl alcohol (IP A)

Methods
A volume of six mL of synthetic spider silk solution was prepared according to the protocol in
Appendix a. A trough of polycarbonate was made with the dimensions 19.8 cm x 1.5 cm x 2 cm
using epoxy and cyanoacrylate (Figure 10). The trough held 59.4 mL of solution. A minimum of
20 mL of solution were needed to submerge the catheter which was impractical and wasteful. To
decrease the necessary volume of spider silk, an insert piece of polycarbonate was added to the
trough (Figure 11). The new dimensions of the trough were 6.5 cm x 1.5 cm x 2 cm. To
submerge the catheter in this new setup, approximately 6 mL of solution were sufficient. It was
discovered that using more than six mL of solution at a time caused the solution to gel before the
coating process was finished.
Uncoated catheters were pierced through one of the forked ends with a needle, then a length of
fishing line was pulled through the hole to tie a loop, while another length of fishing line was
used to create a loop at the tip of the catheter (Figure 12). The loops were used to pull the
catheter through the trough to avoid unnecessary contact. With the smaller trough, touching the
catheter while coating was unavoidable. Contact was kept to just below the forked end and at the
very tip where the coating would drip down while drying.
Prior to coating, the catheters and the trough were sterilized in a 10% bleach solution for lO
minutes then rinsed with 20% IP A The sterilization step was required to prevent contamination
during the antimicrobial trials. All 6 mL of solvated synthetic spider silk or synthetic spider silk
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solution with chlorhexidine were pipetted into the trough . The catheter was pulled through
solution, rotated , and then pulled back through to ensure full coverage. Once both passes were
complete, the catheter was hung from a ring stand to dry for approximately five minutes (Figure
13). A total of three coatings were deemed necessary based on literature (Lewis , 2016).
A blue food coloring was added to the solution during some initial trials to easily visualize the
coating . The coloring made it easier to see the bubbles trapped on the surface of the catheter
from bubbles that formed while pipetting the solution into the trough . This was mitigated by
pipetting very slowly into the trough .
Based on industry needs , the team attempted to create an inside coating using the dip method .
The catheter was pulled through the trough, the opening on the forked end allowed the coating
solution into the catheter. Excess solution was then pipetted into the catheter while hanging from
the drying apparatus , moving the catheter around the inside to assist in a consistent coating. The
coating then dripped out of the opening in the tip of the catheter .

F'igure JO: The polycarhonale trough.

J<'igure11: Insert addition to reduce l'Olume qf trough.
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Figure J2: Looped.flshi11g line to pull the catheter and hang

lo

d,y.

Figure 13: The apparatus to hang d,y the catheters.

Conclusion
The dip coating method left a visible coating on the catheters , but the food coloring made the
bubbles on the surface stand out. The catheters needed to dry after coating for several hours, but
the catheters remained sticky after drying . The dip-coated catheters made a crinkling sound when
bent.
The inside of the catheter near the forked opening appeared to be evenly coated ; however, later
SEM imaging revealed that the inside was not consistently or evenly coated .
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2. Aerosolize Coating

Materials
• 6% w/v Spider Silk Solution
• 20% Chlorhexidine solution
• Isopropyl Alcohol (IP A)
• Ultrasonic Lumiscope Nebulizer (Model 6700)
• Salter Labs Nebulizer (Model: 8900-7)
• Glass vacuum adapter
• Vinyl hose , l" O.D .
• Urinary catheters
Methody
A two mL solution of 6% (w/v) synthetic spider silk solution was prepared in a glass vial via
protocol in Appendix a. The solution was pipetted into a portable Lumiscope ultrasonic nebulizer
to coat a catheter sterilized in a 10% bleach solution and rinsed with IP A The first coating
attempt was aimed at coating the inside surface of the catheter. A glass vacuum adapter was
purchased in order to connect to the vacuum outlet in the fume hood . The catheter was attached
to one end of the adapter and held by hand in the other. The vacuum and nebulizer were turned
on and the nebulizer nozzle was focused into the tip of the catheter . The aerosolized synthetic
spider silk solution was difficult to see which made it impossible to determine if the inside of the
catheter was coated effectively . It appeared that the synthetic spider silk was not exiting the
nebulizer in a continuous stream and upon inspection it was determined that the solution had
solidified. The Lumiscope model that was being used relied on an outlet and could handle a
maximum of fifteen watts of power . Unfortunately, the nebulizer was not strong enough to
aerosolize the solution.
The team decided to reduce the percentage of synthetic spider silk in solution to 3% (w/v) to
ensure release by the nebulizer and to find a new nebulizer that relied on an air source instead of
a battery . A new nebulizer was purchased from Alpine Medical made by Salter Labs (Model :
8900-7) . An e,,.rtravinyl hose (1" O.D.) was purchased with the idea of creating a "T" shape with
the existing hose . The catheter could then be placed through the two hoses which would allow
the synthetic spider silk solution to aerosol down the two hoses and across the entire catheter.
After discussing this idea, it was discarded for three difference reasons. First , the vinyl hose that
was purchased was too small to fit around the "T" attachment of the nebulizer. Second, the
synthetic spider silk is only released out of one side of the "T". This means that only one side of
the catheter would be coated with synthetic spider silk. Lastly , the catheter would not be coated
evenly . The middle of the catheter would have a thicker coating than the two ends because the
synthetic spider silk meets the middle first before moving outward more slowly .
The next coating trials were performed using the new nebulizer with a 3% (w/v) and 6% (w/v)
synthetic spider silk solution. The air connection was only available on a lab bench so the
coating was performed outside of the fume hood. The catheter was hung from a ring stand with
fishing line and the nebulizer head was passed down the catheter and back up. This up and down
coating motion was repeated rotating around the entire catheter. Both the 3% and 6% solutions
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were aerosolized and sprayed onto the catheter with two coatings with a ten-minute break in
between for drying .
Although the new nebulizer successfully released the spider silk as an aerosol, it was difficult to
determine whether the synthetic spider silk was adhering to the catheter. During the next coating
trial, red food coloring dye was added to the synthetic spider silk solution after centrifugation
and before it was pipetted into the medicine cup to help visualize attachment of the synthetic
spider silk to the catheter. The nozzle head was also turned 90 degrees so that it was parallel to
the hanging catheter instead of perpendicular as in the previous trial. This directed the
aerosolized synthetic spider silk up and down the catheter.
Previously , the solution was moving around the catheter which reduced the amount of surface
area that was coated . A three rnL solution was used for a total of three coatings . There was an
obvious red discoloration to the nebulizer hose and attachment but not to the catheter . An
additional three rnL of synthetic spider silk solution was used to coat the catheter for three more
coatings . Upon inspection , there appeared to be a change in color to the catheter as well as a
matte finish that contrasted with the initial shiny appearance of the surface.
Antimicrobial testing with samples from the coated catheters verified coating results from the
nebulizer trials and results are discussed in the antimicrobial testing section . The 3% synthetic
spider silk coating had no effect on antimicrobial properties . Therefore, it was decided not to
continue with this coating method. The 6% synthetic spider silk coating showed inhibition to
bacteria growth but the coating was not as effective as other coating methods such as dip coating .
Using the nebulizer as a coating method is still a viable option but serves better as a secondary
coating method . Since antimicrobial results showed that a combination of coating methods seems
to be the most effective at inhibiting bacterial growth, a new coating option was created : dip coat
with a secondary aerosolize coat.
It was also decided to attempt an inside catheter coating with the nebulizer. To accomplish this, a
nozzle apparatus was created by the team and is shown in Figure 14. Cake decorating tips were
attached to one end of the hose using tape so that the tip could be inserted into the open end of
the catheter (Figure 15). The other end of the catheter was attached to the glass vacuum adapter
using piping bags and tape (Figure 16). The nebulizer was connected to the air source on the
bench top and the vacuum adapter was attached to the vacuum source in an attempt to create a
continuous flow of aerosolized synthetic spider silk solution through the catheter . The vacuum
pulled the air through the catheter and cooled it down which caused the synthetic spider silk
solution to aerosolize. This was visible when the nozzle was removed from the catheter and led
us to believe that the inside coating had coagulated . In order to determine if this was the case,
SEM imaging was performed for this method . SEM images of the inside coating are shown in a
later section.
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Figure J../: Image of'appararus set upfc,r rhe inside aerosolize coating method.

r

Figure 15: Image olthe nozzle that was designedfor the inside aerosolize coating method.
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Fig11re 16: Image showing the vacuum adapter set up for the inside aerosolize coating method

Ftgure J 7: Image that shows coag11/ation of the spider silk c1fieran attempt to coat the inside of the
catheter .
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Conclusions
The aerosolize coating method is very straight forward and easy to set-up. However , the
synthetic spider silk aerosol that is released by the nebulizer creates a thin coating . Because of
this, it is recommended that the aerosolize coating method be used as a secondary coating
method if a thicker coating is desired.
The catheter felt cool to the touch when the above -mentioned protocol was used in an attempt to
coat the inside . As shown in Figure 17, the synthetic spider silk solution precipitated from
solution and formed beads. This led to the assumption that if the inside was coated it was most
likely an uneven surface of coagulated spider silk solution .
3. Spray Coating

Materials
• 6% w/v Spider Silk Solution
• 20% Chlorhexidine solution
• Airbrush Master Series II
• DACA Winder
• Steel Rod 70 cm in length
• Urinary Catheters
Method,;
Before coating , the apparatus used to generate uniform rotational velocity was prepped . The
DACA winder featured a steel bar that was 25 mm in diameter and 220 mm long. Approximately
40 mm of the bar at the suspended end was threaded. The mounted end is connected to the motor
that rotates the bar at tunable velocities . A 3D printed mount was designed in SolidWorks and
constructed of poly lactic acid. It included a hollow cylindrical end with a 45 mm outsi de
diameter , a 19 mm inside diameter , and is 40 mm long . The center of the mount was originally
designed as a transitional piece with a stepped cut to accommodate different sized catheters
(Figure 18). This design was modified when the decision to no longer test IV catheters was
made . A tapped hole in the fixture threaded the hollow end of the mount with grooves to match
those of the steel bar . Once the grooves were tapped into the mount it was placed onto the steel
rod by screwing the threaded pieces together. The catheter was cut and attached to the small
diameter until it fit tightly and was centered on the winder (Figure 18).
The DACA winder was a key element in the spray coating method because its constant rotation
promotes continuous coating across the catheter surface. An issue arose in attempting to
attach Foley catheters to the rotational piece. It was impossible to maintain a permanent position
for the Foley catheter so a fixture was designed to fit on the DACA winder rotating arm with a
snug fit for catheter hubs to be inserted to. To create such a fixture , dimensions of the winder
were measured using calipers to determine the diameter , length, peak length and pitch of the
threads. The drawing seen in image Figure 19 was the initial design for a mounting solution . The
final design was then sent to the USU 3D printing office using ABS plastic in a low density
setting to decrease the amount of overall materia l used in the printing process .
Exact dimensions were difficult to obtain so plumber ' s tape was wrapped around the threaded
portion of the DACA winder rotating arm several times to thicken the diameter and fill in the
36

gaps (Figures 20 and 21). This served to further secure the mount and ultimately proved as a
successful solution to mounting IV catheters.
The fixture to be added to the mounting assembly was designed in a way that it could be
inserted into the original DACA winder mount. This converted the initial part from mounting IV
catheters to being able to mount Foley catheters (Figure 22) . The final design was then sent to
the USU JD printing office using ABS plastic in a low density setting to decrease the amount of
overall material used in the printing process (Figure 23) .
After the mounts were completed and assembled the first coatings began. Once the DACA
Winder was started , the "Winder Only" option on the display was selected . The prompt to enter
the spool diameter (outside diameter of catheter) in millimeters and 30mm was entered . The
winder speed was set at 6 meters per second (mis) . The last prompt was to choose the step size of
each velocity increase which was set at 1 m/s. These parameters were not chosen to be accurate
to the diameter of the catheter. They were instead chosen as a benchmark for all the catheters to
be coated at the same speed . It was imperative that the winder spin quickly enough to get a thin
even coating , and that the rotational speed (winder settings) was uniform throughout coatings.
Before winding , the catheter was to be marked with a pen to distinguish the start and stop
positions for the air brush.
Using the Airbrush Master Series II 6% synthetic spider silk solution was loaded into the liquid
chamber of the airbrush gun . The airbrush features a small air compressor and mechanical
settings designed to tune the quantity of liquid allowed to disperse into the otherwise constant
airflow . Of, course this airflow was only constant after it had been allowed to dispense excess
pressure. Because of this, the catheter was only sprayed after the gun had sprayed for several
seconds. The catheter was then moved at a constant lateral velocity along the entire length of the
catheter. The catheter was promptly removed using sterile forceps and secured to dry vertically .
Upon coating the first several catheters , it was discovered that the lateral speed was not
consistent. The DACA Winder features a speed variable guide that travels 14 cm back and forth
parallel to the catheter. However, the guide is offset about 30 cm from the position of catheter
being spun. A steel rod used in the drying apparatus was placed on the operator's shoulder and
the other end on a clamp attached to the sliding guide. The rod would move at a constant velocity
with the guide and slide freely across the shoulder the airbrush would be placed and held at a
constant position along the steel rod . This limited lateral movement of the airbrush to the
velocity preset by the sliding guide . By keeping the preset velocity the same, uniform lateral
movement was permitted across all samples. The limited 14 cm tract of the guide also meant that
the position of the airbrush on the steel rod would need to change to cover the entire length of the
catheter. This required careful observation of where the spray coating ended to align that position
to the spray coating coming from the other direction. Due to human error, double coating for this
small segment of the catheter was inevitable.
Further issues arose with the mechanical settings on the airbrush that moved slightly with the
vibration of the air compressor and would not return to the exact same setting after each use .
This meant the settings were adjusted after each spin and there was no way to detennine if there
were an equal flow rate between trials except to allow the airbrush to spray a glove and the rate
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at which the glove was wetted was observed and adjusted so that it would be similar each time .
The instruments available did not allow measurement of these flow rates to ensure uniformity
over each coating.
40mm

Figure 18: Depiction qf initial iteration.fbr 31) printed mo1111tforuse in catheter .,pray coating
procedures. This design had originalzy considered coatinK IV catheters and was discarded due to
the design changl!from IV catheters to Foley catheters .
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Figure 19 First edition of 31) printed catheter 11101111!.for
DACA winder. lhis second design
iteration was discarded because it did not.fit the dimensions qf the DAC'A winder and thread\ ·
1vere deemed a necessary design addition.
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Figure 20: Final edition of3D printed catheter mount.for DACA winder. 7hreading was added
in the.final design to allow.for a more secure.fit. Accurate thread dimensions were d{fficult to
obtain.from the DACA winder and so plumbing tape was wrapped around the threaded portion
to.fill in spaces hetween the printed part and instrument.

Figure 21: Final iteration c!f3D printed .~pray coating mo11111
secured on DACA Winder . An
additio11alj1xt11rewas later deemed necessary to allow a dowel to be inserted upon which the
Foley catheter would be secured.
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Vigure 22: Complete msemh~JJqf 3/) .\pray coali11gfixt11re.additional do11'el.flxt11re,and dowel
held securely 011 DACA winder.
2

f',,"-.,__ All Corne rs
R.51

8

8
29.46

I
Aj

I
i_
2

Figure 23: IJetailsfor 3JJdoll'elfixt11re which was designed lo allow a metal rod to he al/ached
lo the l1'inder. The catheters H'ere slid O\'er the rod lo ensure smooth and consistent rotation.
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Conclusions
The spray coating method required several moving parts and dried almost immediately upon
contact due to the use of compressed air as a mobilizing spray . The coating was difficult to
observe with the naked eye, and SEM imaging was performed to ensure the spray technique
provided a uniform coating . Images confirmed that the coatings were present and smooth . Inner
coatings were not feasible and were not attempted with this method .
4. Spray and Dip Coating

Materials
•
•
•

6% w/v Synthetic Spider Silk Solution
20% Chlorhexidine Solution
Latex Urinary Catheters , Spray coated

Method\ ·
After a catheter was coated using the spray coating method , the catheter was allowed to dry for
24 hours . The catheter was then dip coated using the dip coat protocol described previously . The
catheters were sterilized prior to spray coating however , no sterilization took place before the dip
coating . If the first coating contained chlorhexidine , the second layer also contained
chlorhexid ine.
Conclusion
The spray coated catheter became sticky after dip coating. There was less of a crinkling when the
spray and dip coated catheter was bent , but there was still visible cracking in the coating .

5. Dip and Aero solize Coating
Materials
• 6% w/v Synthetic Spider Silk Solution
• 20% Chlorhexidine Solution
• Latex Urinary Catheters , Dip coated

M ethods
A catheter was dip coated and allowed to dry for 24 hours . The catheter was then coated using
the aerosolize method described above . If the first coating method contained chlorhexidine , the
second layer also had chlorhexidine .
Conclusion
After dip coating the catheter had a shine to the surface ; after the additional aerosolize coating ,
the catheter was more matte in appearance . There was less of a crinkling sound when the catheter
was bent as compared to the dip method . However , there were more cracks that showed in the
dip and aerosolize coating compared to just an aerosolized coating .
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iv. Antimicrobial Testing with Coated Catheters
The antimicrobial effect of the catheter coatings needed to be measured in order to meet the
specified design criteria . Zone of inhibition testing served as a quantitative test that allowed for a
final catheter design decision. The bacteria used in initial testing (E. coli, S. aureus, and S.
marcescens) were included in the final trials with catheters coated by the optimized coating
protocols.

Materials
• Liquid Luria-Bertani (LB) media
• Solid LB media with 2% Agar
• Petri dishes
• Sterile cotton swabs
• Catheters coated with optimized coating protocols
Method,;
Antimicrobial testing was performed once catheters were coated with all the final coating
methods. A practice plate was inoculated with different sample shapes to determine which shape
would stay attached to the agar during incubation . Scissors were used to cut an oblong shape and
a scalpel was used to cut a sample of the cross-section (ring) and a rectangle from a dip coated
catheter. A plate was inoculated with S. aureus bacteria and put in the incubator for 24 hours . As
seen in Figure 24, the oblong sample fell off but the ring and rectangle stayed attached to the
agar . The ring showed more uniform inhibition of bacterial growth when compared with the
rectangle sample . Due to this, it was decided that final antimicrobial testing would be
accomplished using a cross-sectional area sample from each catheter. Problems occurred when
the catheters were cut for testing . The silicone catheters were difficult to cut which resulted in
samples that were not completely smoot h and did not lay flat on the agar. To combat this
problem , the samples were gently pressed into the agar once they were deposited .
The zone of inhibition test was performed using E. coli, S. aureus, and S. marcescens. A control
plate was inoculated for each bacteria species. Then, each catheter sample was placed on an
inoculated plate . Each coating method was plated twice. The following is a list of the catheter
samples that were used for testing: 6% synthetic spider silk dip coat, 6% synthetic spider silk and
chlorhexidine dip coat , 6% synthetic spider silk spray and dip coat, 6% synthetic spider silk and
chlorhexidine spray and dip coat , 6% synthetic spider silk spin coat , 6% synthetic spider silk and
chlorhexidine spray coat , 6% synthetic spider silk aerosolized coat, 6% synthetic spider silk and
chlorhexidine aerosolized coat , 3% synthetic spider silk aerosolized coat , 3% synthetic spider
silk and chlorhexidine aerosolized coat, and an uncoated catheter. Zones of inhibition were
measured every day for a total of seven days. Despite pressing the samples into the agar a few
samples fell off during the week of testing which required additional antimicrobial testing .
During the first antimicrobial trial, a dip and aerosolized coating method was created. Catheters
were coated with both a 6% synthetic spider silk solution and 6% synthetic spider silk with 1.5%
chlorhexidine solution . The samples from the new coating method were added to the second trial
of antimicrobial testing . The spray coating protocol was further optimized which required new
samples to be incorporated into antimicrobial testing . Ultimately , the second round of testing
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consisted of any catheter samples that fell off during the previous round , samples from the new
coating methods , and samples from a catheter coated with the optimized spray protocol.
To obtain the necessary number of measurements to ensure proper statistical analysis , a third and
final trial of antimicrobial testing was set up. Samples from all five coating methods with both
6% spider silk and 6% spider silk and 1.5% chlorhexidine were included.
Results
Images for the seventh day of testing for all trials are shown below in Figures 25 through 30. A
scale bar has been added to all pictures for reference . All pictures are available in Appendi x b.
The average zone of inhibition in millimeters is shown for each coating method at day seven for
each bacterium in Tables 5, 6, and 7 below along with the 95% confidence interval values,
standard deviation , and the standard error of the mean .. All measurements for the three bacteria
used can be seen in Appendix b. The values that are shown in the table below were used to
create Figures 31, 32, and 33 respecti vely. Statistical analysis was run using GraphPad Prism
using column statistics and one-wa y analysis of variance (ANO VA) with Tuke y HSD post-hoc
test. Significance when compared to the uncoated control has a p-value less than 0.05 .

..

Figure 2-1:Picture shol1'ing the different sample shapes that were tried lo determine the hes/ one
for antimicrobial testing. From top moving clockwise: cross-section (ring), rectangle, and
ohlong.
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Figul"I!25: Pictures <~/':::ones
c?f'inhihitionfrom trial 1for samples <!lcoaling method\· against g
coli. Descriptions start in the top lefi quadrant and conli1111ec/ock1t'isefor each plate. (1,2) 6%
.\pider silk dip, 6% spider silk
1.5% <:hlorhexidi11edip, 6% ,VJidersilk 1 1.5% chlorhexidine
sprc(y and dip, a11J6% spider silk spray and dip. (3,-1) 3% .spider silk aerosolized, 3% spider silk
; 1.5% chlorhexidine aerosoli:::,ed,6% .5pider silk · 1.5% chlorhexidine .spray, and 6% .spider
silk .spray. (5,6) 6% .spider silk aerosolized, 6% spider silk · 1.5% chlorhexidine aerosolizel/,
and uncoated

Figure 26: PiU11reqf zom:s <!linhibitionfi'om trial /for samples c~lcoating methods against S.
aureus. Descriptions startfi·om the lop lefi quadrant and cont11we clockwise for each plate. (J, 2)
6% spider silk dip, 6% .spider silk i 1.5% chlorhexidine dip, 6% .spider silk 1.5%
chlorhexidine spray and dip, and 6% .spider silk ,\]Jrc~)-' and dip . (3,-1) 3% spider silk aerosolized,
3% spider silk ' f.5% chlorhexidine aero.mli:::ed,6% .spider silk
1.5% chlorhexidine .<,pray,
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and 6% spider silk .~pray. (5,6) 6% spider silk aerosolized, 6% spider silk
aerosolized, and uncoated.

i-

1.5% chlorhexidine

Figure 27: Picture of zone:,;~finhibition.from trial /for samples cif coating methods· against S.
marcescens. Descriptions start from the top left quadrant and continue clockwise for each plate.
(1,2) 6% .~pidersilk dip, 6% spider silk - 1.5% chlorhexidine dip, 6% spider silk i- 1.5%
chlorhexidine spray and dip, and 6% ~pider silk spray and dip. (3,../) 3% spider s;/k aerosolized,
3% .spider silk -+1.5% chlorhexid ine aerosolized, 6% spider silk -+1.5% chlorhexidine spray,
and 6% spider silk spray. (5,6) 6% spider silk aerosolized, 6% spider silk ..,-.1.5% chlorhexidine
aerosolized, and uncoated.

hgure 28: Picture (~{zones of inhibitiunfrom trial 2.for samples of coating me/hod\ · against E.
coli. Descriptions start in the top left quadrant and continue clockwise for em:h plate. (1,2) 6%
.spider silk .\pray, 6% .spider silk t 1.5% chlorhexidine .~pray, 6% .~pidersilk , 1.5%
chlorhexidine dip and aerosolized, 6% .spider silk dip and aerosolized. (3) 6% .spider s;/k " 1.5%
chlorhexidine aerosolized (.mmple /), 6% .spider silk ; 1.5% chlorhexidine aerosolized (sample
2), and 6% spider silk , 1.5% chlorhexidine spray and dip. (./) 6% ,\pider silk aerosolized and
6% spider silk 1.5% chlorhexidine dip and aerosolized.
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Figure 29: Picture of zones <?finhibition.fiwn trial 2for samples qfcoating method, · against S.
aureus. Descriptions start in the lop left and continue clockwise for each plate . {1) 6% ,spider silk
spray, 6% .,pider silk 1.5% chlorhexidine :,,pray,6% :,,pidersilk + 1.5% chlorhexidine dip and
aerosolized, 6% spider silk dip and aerosolized. (2) 6% :,,pidersilk spray, 6% .spidet silk · 1.5%
chlorhexidine .\pray, 6% .spider silk 1.5% chlorhexidine dip and aerosolized, 6% .,pider silk
dip and aerosolized.

Figure 30: Picture <?,/
zones <f inhibition from trial 2 for samples qf coating method, · against S.
marcescens. Descriptions start in lop left and continue clockwise for each plate. (1) 6% spider
silk spray, 6% spider silk -1- 1.5% chlorhexidine spray, 6% spider silk ..; 1.5% chlorhexidine dip
and aerosolized, 6% .\pider silk dip and aerosolized. (2) 6% .spider silk spray, 6% spider silk ""'
1.5% ch/orhexidine .,pray, 6% spider silk 4 1.5% chlorhexidine dip and aerosolized, and 6%
:,,pidersilk dip and aerosolized. (3) 6% :,,7Jider
silk aerosolized and 6% .spider silk , 1.5%
chlorhexidi11espray and dip.
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Table 5: Statistical analysis.for the seventh day zone l?f inhihilion measurements.for E. coli .
Upper95%
Lower95%
Confidence
Confidence
Interval ofMean Interval of Mean

Significant
Compared to
Uncoated

Average (nun)

Standard Error
oft.re Mean

Standard
Deviation

Uncoated

8.00

0.00

0.00

8.00

8.00

No

Spray

8.17

1.67

0.41

7.74

8.60

No

Spray+ Chlorhexidine

8.50

0.27

0.76

7.87

9.13

No

Dip

8.00

0.00

0.00

8.00

800

No

Dip + Chlorhexidine

11.00

1.63

4.00

6.80

15.20

Yes

Aerosolize
Aerosolize +
Chlorhexidine

8.00

0.00

0.00

8.00

8.00

No

8.50

0.50

1.41

7.32

9.68

No

Dip and Aerosolize
Dip and Aerosolize+
C hlorhexidine

8.00

0.00

0.00

8.00

800

No

12.43

0.78

2 07

10.51

14 .34

Yes

850

0.50

1.23

7.22

9.79

No

13.00

0.26

0.63

12.34

13.66

Yes

Spray and Dip
Spray and Dip+
Chlorhexidine

Table 6: Statistical analysis.for the seventh day zone <?finhibition measurements.for S. aureus.

Standard Error
Average (mm)
ofthe Mean

Standard
Deviation

Lower95 %
Upper 95%
Confidence
Confidence
Interval of Mean Interval ofMean

S igniftcant
Compared to
Uncoated

Uncoated

8.00

0.00

0.00

8.00

8.00

No

Spray

9.00

0.51

1.35

7.90

10.39

No

Spray + Chlorhexidine

8.65

1.28

4.04

8.21

13.99

No

Dip

8.17

0.17

0.41

7.74

8.60

No

Dip + Chlort1exidine

13.67

0.42

1.03

12.58

14.75

Yes

Aerosolize
Aerosoliz.e+
Chlorhexidine

8.30

0 .21

0.52

7.79

8.88

No

8.17

0.17

0.41

7.74

8.60

No

Dip and Aerosolize
Dip and Aeroso lize +
Chlorhexidine

8.00

0.00

0 00

8.00

8.00

No

14.60

0 .85

2.56

10.48

14.41

Yes

8.00

0.00

0 .00

8.00

8.00

No

14.17

0.48

l.17

12.94

15.39

Yes

Spray and Dip
Spray and Dip +
Chlorhe:,,,id
ine
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J'ah/e 7: Statistical ana~),'sis.for the seventh day =one <?/'inhibition measurements.for
marcescens .

Standard Error
Average(nm1) of the Mean

Standard
Deviation

Lower95%
Upper95%
Confidence
Conlidencc
Intervalof Mean lntervalof Mean

Significant
Compared to
Uncoated

Uncoated

8.00

0.00

0.00

8.00

8.00

No

Spray
Spray +
Chlorhexidinc

8.00

0.00

0.00

8.00

8.00

No

8.00

0.00

0.00

8.00

8.00

No

Dip

8.00

0.00

0.00

8.00

8.00

No

Dip ·t- Chlorhexidine

10.50

0.22

0.55

9.93

1107

Yes

Aerosolize
Aerosolize+
Chlorhexidinc

8.00

0.00

0.00

8.00

8.00

No

8.00

0.00

0.00

8.00

8.00

No

Dip and Aerosoli7..e
Dip and Aerosol.i7..e
+ Chlorhexidine

8.00

0.00

0.00

8.00

8.00

No

1.1.27

0.65

215

9.83

12.72

Yes

8.00

0.00

0.00

8.00

8.00

No

I l.67

049

1.21

10.40

12.94

Yes

Spray and Dip
Spray and Dip +
Chlorhexidinc

S.
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Figure 31: Data shown are the al'emge zones qf inhibition standard deviation for each
coating method against E.coli. J-,;ach 1111mber
correspond~· 10 one of the spider silk coating type
(J - .\pray, 2 dip, 3 aemsolize, -I dip and aerosolize, and 5 .spray and dip) and the
addition qf ''C ·· represents coatings containing chlorhexidine. Dffferent letters indicate groups
are slalislical~.vd[fferent (p - 0. 05).fi'Oln the control according lo A NOVA with fokey HSD posthoc tests (Graph Pad Prism). To keep thefig11res easy to read, sign[ficance when compared
between coating methodY was not recorded Significance het\l'een coating methods· is detailed in
Appendix.f
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Figure 32: Data sho1F11
are the average zones qf inhibition ' standard del'iatio11for each
coating method against S. aureus. Each number corresponds to one c!f the spider silk coati11g
type (J -- spray, 2 ~· dip. 3 aerosolize, -I dip a11daerosolize, and 5 .\pray and dip) and the
addition qf "C" represents coatings containing chlorhexidine. Different letters indicate groups
are statistical~y d{fj.-erenl(p · · 0.05).from the control according to ANO/.'A with Tukey HSD posthoc tests (GraphPad Prism). To keep the figures easy to read significance when compared
between coating methods was not recorded 5.,'ig11[fica11ce
between coaling methodv is detailed in
Appendixf
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Figure 33: Data sho1m are the average zones of inhibition standard deviation for each
coating method against S. marcescens. Each number correspond\ · to one lfthe .,pider silk
coating type (J spray, 2 dip. 3 aerosolize, ../ dip and aerosolize, and 5 spray and dip)
and the addition qf ''C ,. represents coatings containing chlorhexidine. Ddferenl letters indicate
groups are statistically d{/ferent (p 0.05).from the comrol according to ANO VA with lzrkey
HSD post-hoc lests (GraphPad Prism). To keep the.figures easy to read significance when
compared between c:oatingmethod, · was 110I recorded. Sign[flcance he/ween coaling method~·is
detailed in Appendix/
Conclusions
The results collected from the antimicrobial trials showed that spider silk alone does not provide
a sufficient antimicrobial coating . The samples coated with synthetic spider silk and
chlorhexidine showed much greater zones of inhibition than the samples that did not. Statistical
analysis showed that the dip with chlorhexidine, dip and aerosolize with chlorhexidine , and spray
and dip with chlorhexidine coatings exhibited significantly larger zones of inhibition than the
other coating methods when compared to the uncoated catheter.

v. Friction Testing
The addition of a coating to the exterior of a urinary catheter will either increase or decrease the
amount of force required to insert the device into the urethra of a patient. For this reason , a
friction test was deemed necessary to evaluate the change in mechanical properties of coated
catheters versus uncoated ones . The goal of this test was to prove that adding a layer of synthetic
51

spider silk coating will either decrease the resistant force/friction of silicon with skin, or maintain
the same amount of force and demonstrate that the coating does not adversely affect the
mechanical properties of a catheter. Several methods and approaches were attempted before
finding a protocol that accurately measured the differences in friction between catheters
accurately.

Materials
• 8-32 six-inch-long dowel rod
• 8-32 nut
• 10-32 one inch bolt
• 10-32 washer
• 10-32 nut
• MTS tensile tester (lateral and vertical)
• 10 N load cell
• Pneumatic grips
• TestWorks 4 Software
• High Strength High Temperature Silicon Rubber Sheet (J/16 ")
• Scissors
• Marking pen
• 2 large clamps
• 5 stackable height test tube pieces
• Copper pipe with set screws
• Hex wrenches
• Needle nose pliers
• Punch press set
• Hammer
• Fishing line
• Size 2 sewing needle
• 4"x l" scrap metal
Method 1
Several pieces of the silicon sheet were cut into one inch square pieces using scissors and
punched through the center using a punch press set and hammer. This created an 11-mm
diameter hole . The squares were then stacked to a height of approximately four inches and laced
together using fishing line and a size two sewing needle . This fixture was made to simulate a
human urethra. A 10-32 bolt and corresponding washer were attached at the end of the four-inch
fixture and sewn on with 4 additional squares. A 10-32 nut kept the bolt secure within the silicon
urethra . This fixture was then mounted to the lateral MTS and a catheter was placed in the
pneumatic grips on the opposite side. As the load cell detracted , it measured the amount of force
necessary to remove the catheter from the urethra .
Changes to Method 1
The urethra was too flexible under its own weight upon attachment to the lateral MTS and could
not maintain a horizontal position to allow for accurate measurements. A piece of sheet metal
scrap was bent to the outer shape of the urethra and a hole was extruded from the side to attach at
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the bolted end of the urethra and provide further support . The supported fixture could maintain
its horizontal alignment ; however , the force of the catheter being pulled outward still bent the
silicon urethra downward slightly and created unusable measurements (Figure 34) . Ultimately ,
the lateral MTS was deemed a non-viable option because of the variability between each
measurement.

Figure! 3-1:Preli le view qf silicon urethra attached to lateral MJ:,;.,_\'lightbe!nding <!/the.fixture
can be seenf,'om the desired 180° position.
Method 2
This second method utilized the silicon urethra assembled in method one, however the vertical
MTS was used instead (Figure 35) . This reduced variability between catheter trials and created
more stability in the overall assembly . An 8-32 six-inch dowel was inserted into the catheter to
ensure that for each test run, the catheter moved over the same path as the previous trial and
output. The urethra was placed on the base of the MTS and the catheter was gradually pulled out
of the fixture . To do this , the dowel inserted into the catheter was attached to the 10 N load cell
using a copper pipe with set screws to convert the 8-32 diameter bolt to the appropriate size for
the MTS .
Change s to Method 2
The data from this set up was still too variable due to ineffective clamps attached to the load cell.
Several shims were placed to create a tighter fit and the positions of the silicon fixture and
catheter assembly were switched . The 8-32 dowel was bolted to the base and the urethra was
attached to the clamps of the load cell and moved up and down to simulate an insertion
procedure . However, the program still did not output consistent results.
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[,igure 35: test set up.for method 2. !he position qf the silicon urethra and catheter 11'ere
reversed to see ff the location </each qffected the res11/ls.
Method 3
It was made apparent by methods one and two that perhaps the interior of the silicon urethra was
not completely uniform and could be the cause of so much variation between test samples . The
fixture was therefore not included in method 3. This third method utilized the remaining sheet of
silicon to simulate the force a catheter needs to overcome the friction coefficient between the
surface of the catheter and the urethra of a patient. Continuing to use the vertical MTS , five
stackable test tube holders were placed on the base of the MTS and held in place by two large
table clamps (Figure 36). A 9-mm hole was punched through the silicon sheet using a hammer
and punch press. This smaller hole caused a more uniform force to be measured as the catheter
was inserted through it and contacted the sheet on its entire circumference (Figure 37) . This
piece of silicon sheeting was then placed between the first and second stacked test tube holders
and the clamps were replaced to hold the material taught and centered on the measurement
system.
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Figure 36: /'est set up for method three. Lateral view<?/the set up. Jhis test method proved to be
the most acrnrate by.far qf the 1hree methods al/empted.for thisfriclion measureme11t lest.

Figure 37: Aerial view <!flhe set up.for lest method 3 without catheter al/cu:h<!d.

Results
Method 3 proved successful in providing consistent data for each catheter and little variation
between catheters of the same coating as evidenced in Figures 38 and 39 . Slight differences in
force required for insertion were measured between coating methods and accurately account for
the difference in surface which is readily described by the SEM images taken prior to this
friction evaluation. The statistical analysis was run using GraphPad Prism software for a one55

way ANOV A test. The data of these trials are shown in Tables 8 and 9. All friction data can be
seen in Appendix d and complete statistical analysis can be seen in Appendix f. Overall , the
coated catheters proved much easier to insert than the uncoated catheters and demonstrate that a
synthetic spider silk coating decreases the friction involved in insertion .
Tah/e 8: 5.'latislical analysis r!f the m •era!-[ei11sertionforce for each qf the catheter coat in[?
method~·
Lower95%
Uppe r 95%
Confidence
Confidence
lntervdl of Mean Interval of Mean

Signilbmt
Compared to
Uncoated

A verag.cForce
(N)

Standard En·or
of the Mean

Standard
Deviation

Uncoated

3.764

0.06836

0.205 ]

3.606

3.922

No

Spray

0 73

0.05

0. 15

0.62

0.85

Yes

Spray + Chknhexidine

0.74

0.05

0.15

0.6 2

0.85

Yes

Dip

0 74

0.05

0. 15

0.62

0.85

Yes

Dip + Ch.lorhexidine

115

0 16

0.47

0.78

1.51

Yes

Aeroso lize
Aerosolize+
Chlorhexidine

0 83

0 11

0.34

0.57

1.09

Yes

1.36

0. 15

04 5

1 02

1.70

Yes

Dip and Aerosolize
Dip and Aerosolize +
Chlorh.exidine

1.30

0 .23

0.69

0. 77

1.83

Yes

102

0.1 5

0.46

0.63

1.38

Yes

Spray and Dip
Spray and Dip +
C hlorhexidine

1.34

0.3 1

0.93

0.63

2.06

Yes

0.66

0.06

0. 17

0. 54

0.79

Yes
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Table 9: Statisfi(;a/ analysis qf the maximum insertion.force.for each qf the catheter coating
methods

Standard Error
Max Force (N)
of the Mean

Standard
Deviation

Lower95%
Upper95%
Confidence
Confidence
Inte1val of Mean Interval ofMean

Significant
Compared to
Uncoated

Uncoated

4 01

0 .06

0. 19

3.86

4.16

No

Spray

l.05

0.05

0.15

0.94

1.17

Yes

Spray + Chk>rhexiline

1.05

0.05

0.15

0.94

1.17

Yes

Dip

1.73

0 .24

0.71

1.18

2.27

Yes

Dip+ Chlorhexiline

1.45

0.14

0.42

1.12

1.78

Yes

Aerosolize
Aerosolize +
Chlorhexiline

1.27

0 .09

0.28

105

1.48

Yes

1.81

0.14

0.41

1.49

2 . 13

Yes

Dip and Aerosolize
Dip and Aerosolize+
Chbrhexidine

1.63

0.23

0.68

1.11

2.15

Yes

1.44

0.14

0.43

l.l 1

1.77

Yes

Spray an:! Dip
Spray and D~) +
C hbrllc:xidine

1.75

0.30

0.91

1.05

2.45

Yes

1.05

0.07

0.21

0.89

1.21

Yes
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Average Insertion Force
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Figllre 38: Data shown are the mean inserliunfor ces · SlcMfor each coating method. l•,ach
llllmber corre.sponds to the spider silk coating t)pe 011 the project overview and the addition of
"(' ,. represellfs coatings · contai11i11gchlorhexidine. D[ffere111fellers indicate groups are
statistically d(fferent (p · 0.05) according to ANO/ 'A with fokey HSD post-hoc tests (GraphPad
Prism).
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Figure 39: Dara shown are lhe max inserlionforces , Sl·Mfor each coating method Leich
number correspond\ · to the ,\pider silk coati11g type on the project overview and the addition ql
·'C" represents coatings containing chlorhexidine. D[fferent letters indicate groups are
statistically different (p 0.05) according to ANOT:4 with Tukey HSD post-hoc tests (Graph Pad
Prism).
Conclusions
The results obtained from the third friction test method indicated the addition of all coatings to
the Foley catheters decreased the force needed for insertion. Uncoated Foley catheters required
approximately 4 N of force during insertion through the 9-mm diameter silicon hole , while
coated catheters required less than 2 N forces . Several coating methods displayed statistical
difference between insertion force values (Figure 3 8 and 39) . A summary of all decisions made
to design the friction test is shown in Figure 40.
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Figure ./0: Design tree detailing the design decisions del'ldopedforfriction testing.
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vi. Bend/ Bunch Testing
Catheter insertion is an uncomfortable exper ience for all patients, but is especially uncomfortable
for male patients . Due to the longer male urethra and the presence of a prostate, catheters must
be flexible during insertion . It is critical that the coating on a catheter does not tear off when it is
bent. Ideally, catheter coatings would stay consistent and would not crack during bending, but
this is not critical to catheter function . Should a catheter coating crack and flake off of the
catheter, this could contaminate any urine samples drawn from the catheter. However, cracking
would not affect samples and would not compromise the function of the catheters . Furthermore,
most elderly male patients have enlarged prostates which cause catheters to bunch at the end.
The characteristics of the coating must be tested when the catheters are bunched at the end. To
test the coating characteristics under bend/ bunch conditions, a testing fixture was 3D printed to
hold catheters in a bent position while they were imaged.

Materials
• AmScope Light Microscope
• Onshape .com Online CAD program
• 3D printer
• Coated catheters
Methods
First, a bunch test fixture was designed using SolidWorks. The idea of the first iteration of the
part was to place catheters inside a curved tunnel for 3 hours and image after removal using light
microscopy . The design drawing is shown in Figure 41 . The first part iteration was designed with
holes in arcs with 1, 2, 4, 8, and 16-inch diameters.
With this experimental design , however , the catheters were imaged in a straightened position ,
minimizing the ability to view cracking and flaking. Because coating visualization was far easier
when catheters were bent , a new fixture design was necessary . Furthermore, the 1-inch and 2inch diameter holes were removed after examining catheter usage in clinical settings. Catheters
will never be bent to that angle without becoming bunched . Therefore, the bunching portion of
the test would cover these diameters . The drawing of the final iteration of the testing fixture is
shown in Figure 42.
The second testing fixture allowed images to be taken while the catheters were held in a bent
position. Catheters were placed in each arch and imaged using the AmScope light microscope at
5X magnification , starting with the 16-inch arc .
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Results
The results of the 50.4 mm diameter arc and bunch tests are shown in Figures 43 and 44 . All
images are available in Appendix c. Note the cracking visible in most coatings when bunched.
Though the coatings did crack , none flaked off the catheter . A summary of all results is given in
Table 10.

Figure ../3: Catheters placed in the 8-inch diameter arc. All images on the left are without
chlorhexidine. (J) Spin (2) Dip (3) Aerosolized(../) Dip and aerosolized, (5) ,Spin and dip. Note
the cracking Fisible in images (2), (../),and (5).

Figure ../../:Catheters bunched at tip. All images on the le.fi are without chlorhexidine. (1) Spin
(2) Dip (3) Aerosolized(./) Dip and aerosolized, (5) 5,JJinand dip. Note the cracking 11isiblein
images(]), (2), (../), (5).
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Table JO: ,S'mnmWJ'of'Rend Hunch test results.
8 inch arc
Coating Type
Crack? Flake?
No
No
Spin
No
No
Spin + Chlorhexidine
Yes
No
Dip
Yes
No
Dip + C hlorhexidine
No
No
Aerosolized
Aerosolized + Chlorhexidine
No
No
Yes
No
Dip and Aerosolized
Dip and Aerosolized + Chlorhexidine
Yes
No
Yes
Spin and Dip
No
No
Spin and Dip+ Chlorhexidine
No

Bunch
Crack? Flake?
Yes
No
No
No
Yes
No
Yes
No
No
No
No
No
Yes
No
Yes
No
No
Yes
Yes
No

Conclusions
As shown in the figures above , all coating methods except for the aerosolized coating cracked
during bunch testing . Because the catheters only cracked and did not flake off, the coatings
would not affect any diagnostic samples taken from the catheter in clinical use. Each of the
coating methods was determined to be a viable method based on the bend/bunch testing
parameters .

vii. AFM Imaging
Materials
• Atomic Force Microscope (AFM)
• Glass Microscope Slides
• Double Sided Tape
• Coated and uncoated catheters
Methods
A section of catheter was cut into a l 0-cm strip. The bottom of the strip was uniform to avoid
any bumps or inconsistencies that would prevent the AFM from obtaining a clear image. The
strip was then secured to a glass microscope slide using double sided tape and placed under the
cantilever of the AFM . The AFM was set to tapping mode and the cantilever was lowered onto
the sample until contact was made. The AFM measured the topography of an area between 2500
and l 0000 µm 2 and a 2D image was created . Three images of each catheter were taken . Once the
image was taken, the mean roughness of each catheter was measured using the AFM software
and 3 D images were created for several of the catheters .
Results
All 2D AFM images can be found in Appendix e. A 3D image of an uncoated catheter is shown
in Figure 45. A 3D image of a dip and aerosolize coated catheter with chlorhexidine is shown in
Figure 46. A 3D image of a dip coated catheter with chlorhexidine is shown in Figure 47 . These
images are shown for their high quality and the consistency across coating types. The mean
roughness measurements of the catheter images are shown in Table 11. There are large
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differences between images of the same catheter due to micro-imperfections in the coatings such
as cracks.

Figure -15:31) image qf'the topography <!fan uncoated catheter. The scall si::e ill the horizon/a/
directions is 50 ,um and the data scale in the vertical direction is 3 ,um.

Figure -16:JD image £!/the topography qfa dip and aerosolize coated .\pider silk and
chlorhexiJine catheter. The scan size in the horizontal directions is 50 ,um and the data scale ill
the vertical direction is 3 pm.
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Figure ../7: 3D image of the topography <fa dip coated .\fJider silk and chlorhexidine catheter .
lh!! scan size in the hori::olllal directions is 50 µm and the data scale in the vertical direction is

3pm.
Table JI: 771emean roughness qfcathelers calrnlatedfi·om AI·M images.
Coating

Image 1 (nm) Image 2 (nm) Image 3{nm) Average(nm)

Uncoated

73.005

61.453

63.65

66.036

Dip

131.74

244.22

88.15

154.703

Dip with Chlorhexidine

88.332

45.316

68.841

67.496

Aerosolized

146.76

76.845

375.52

199.708

Aerosolized with Chlorhexidine

102.62

107.8

550.7

253.706

Spray

192.71

221.95

315.36

243.34

Spray with Chlorhexidine

248.18

86.586

99.953

144.906

Dip & Aerosol ize

29.053

26.633

46.694

34.127

73.208

191.04

163.53

142.593

Dip & Spray

76.279

113.78

44.097

78.052

Dip & Spray with Chlorhexidine

73.164

168.95

271.59

171.235

Dip & Aerosolize with
Chlorhexidine

Conclusions
Several divots can be seen in the image of the uncoated catheter. Divots are an optimal location
for bacterial colonization, increasing the risk of CAUTis . Both 3D images of spider silk coated
catheters show smooth surfaces with no divots . Though several bumps can be seen on the
surfaces, they are not optima l locations for bacterial colonization due to their smoothness . The
crack seen in Figure 47 is similar to cracks seen in many other images and is likely a gap
between different drops of spider silk. This could be a possible attachment point for bacteria ,
though the antimicrobial properties of the coating would inhibit bacterial growth in these areas .
These images show the relative smoothness of coated catheters.
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viii. SBM Imaging
Materials
• Scanning Electron Microscope (SEM)
• SEM sample mount
• Coated catheters
Methods
Catheter samples of each coating method were cut transversely to an approximate thickness of 1
cm, secured to an SEM sample mount, and placed in the machine . Imaging was carried out in the
SEM under vacuum . FenAnn Shen operated the instrument with all group members present to
help direct the process.
Results

Several representative SEM images displaying the measured thickness of the synthetic spider silk
coating are shown in Figures 48 through 55. Appendix e contains all SEM images taken. The bar
at the bottom of each image shows the conditions used during imaging including the
magnification . A scale bar is also shown for reference.
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Figure -18: Sl~M image ~la spray coated catheter . The SJ.,,M s~fiware u·as used to measure the
thickness c?fthe coating (J. J33 µm).
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Vigure ../9: SEA1image l!{ dip coated catheter . ]he ,\'/·M s(?fiware was used to measure the
thickness (?fthe coaling (I . 759) and the distance.fi·om the catheter to the top <!fthe flake (../.0../9
µm) that was caused by cutting with a razor hlade .

10µm
d,pchloro-razercut

Ngure 50 : SfcNl image qf a dip coated catheter
ch/orhexidine.
measure the thickness qfthe coating (1.51 I µm).

the SJ,,M .w?ft11
are
1

11·a .'I

used to
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Figure 5 J: .S'J
~M image <!faerosolize coaled catheter. /'he Sl~M scltware was used to measure
the thickness of the coating (J.02 7 µm) .
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hgure 52: SJ,,M image (!f dip and aerosolize coated catheter. The S'l:Msqftware was used to
measure the !Mc/mess <l the coating (J.512 µ111)
.
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Figure 53: SJ.;A,1
image <!fspray and dip coated catheter. The S'J~'/'vf
sqfiware was used to measure
the thickness of the coati11g (2.952 µm).

Figure 5-1:SJ~Mimage qf aerosolize inside catheter coating The SF.Msqfiware ll'as useJ to
measure the thickness <!(three d[(ferelll coating head\ ·. From left to right: 20.25 µm, 1-1.8.Jµm,
and J2. 1./ µm.
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Figure 55: SE!vfimage c!fdip inside catheter coating The SJ,,M s~ftware was used to measure
the thickness qfa coating bead(/. 769 µm).
Conclusions
The SEM images that were obtained provided qualitative results to whether the applied coatings
were smooth. Dip, dip and aerosolize , and spray and dip all showed very smooth su1faces. The
spray and aerosolize methods appeared much rougher . The catheters were difficult to cut due to
the latex material that they are made of This resulted in the appearance of flaking in some of the
SEM images.
SEM images is very time consuming so all of the catheter samples that were imaged were
synthetic spider silk coating without chlorhexidine . FenAnn Shen assured the group that the
addition of chlorhexidine would not change the SEM pictures in any way . However , in order to
be sure of this, the team decided to image a dip coated catheter and a dip coated catheter with
chlorhexidine in order to ensure that the coatings were similar (Figures 49 and 50 respectively) .
The resulting thicknesses were l. 759 µm and 1.511 µm respectively however, no other
differences were noted . This confirmed that imaging only the synthetic spider silk coated
catheters was sufficient.
Industry leaders expressed interest in a catheter that is coated on the inside as well. As
mentioned in the coating protocols above, the team developed an aerosolized inside coating
method and dip inside coating method to meet this interest. However , the SEM images revealed
that neither method created an even coating (Figures 54 and 55) since there was no way to
control the flow of spider silk through the catheter in either method . Due to time constraints , the
team decided to stop investigating methods to create an inner coating .
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7. Final Design Review
A summary table (Table 12) was created evaluating the various catheter coating methods based
on the design criteria : antimicrobial activity, insertion friction, surface roughness , coating
flexibility , and production feasibility . For antimicrobial activity , coatings that had statistically
significant zones of inhibition when compared to uncoated catheters were given one point for
each bacteria species (total of three) . Coating methods that significantly reduced friction when
compared to an uncoated catheter were given a score of one . Roughness was given a qualitative
score based on SEM imaging : a smooth appearance received a one while a rough appearance
received a zero . The coating flexibility was based on the bend bunch test. Coating methods that
did not crack received a one, and coatings that did crack scored zero. The feasibility scores were
based on the team's opinion on ease of manufacturing . A score of two is ease of manufacturing
compared to the current process of creating urinary catheters ; a score of one is harder to
manufacture than the current process , and a score of zero is a non -feasible coating for
manufacturing . Based on this scoring process , the best coating methods were dip with
chlorhexidine , spray and dip with chlorhexidine, and dip and aerosolized with chlorhexidine .

Table J2: Summary q/Fmluation Criteria

Uncoated

Antimicrobial:
Frict io n :
Roughness:
Bend/Bunch:
Ease:
Total:

Dip

0
0

0
1

0
1
2

0
0
2

3

3

Dip with
Spray with
Aerosolized
Chlorhexidine Spray Chlorhexidine

Aerosolized
with
Chlorhexidine

Spray and
Dip

Spray and Dip
with
Chlorhexidine

Dip and
Aeroso 1ized

Dip and
.
.
Aerosohzed with
Chlorhexidine

0
1

0
1

0

1
0
0

0
1

0

0

0

0

1

1

0

3
1
1
0

2

0

0

0
1
1

0
1
1
0

0

1

1

6

1

2

3

3

2

5

3

6

3

0
1
1

0

3
1
0

8. Conclusions
Multiple methods for coating of urinary catheters using synthetic spider silk were developed .
However, results showed that only three coating methods exhibited significant antimicrobial
properties . All methods were scored on their antimicrobial properties, insertion force
requirements, surface roughness , ability to resist flaking when bent and bunched, and mass
manufacturing feasibility . Two coating methods tied for the highest score: the dip with
chlorhexidine and dip and aerosolized with chlorhexidine . However , because the feasibility score
is based on qualitative results, the team recommends the dip and aerosolized with chlorhexidine
coating as the best catheter coating to reduce the risk of CAUTis .
Catheters coated using this method met all of our design objectives and, in particular , showed
statistically significant larger bacterial zones of inhibition against three UTI-causing bacterial
strains . This was the most important objective for the product because significant antimicrobial
properties will reduce the possibility of CAUTis. It was further determined that this coating
requires a smaller force to insert through a synthetic urethra analog which means that the coating
is smoother than uncoated Foley catheters . The coating did not flake off when the catheter was
bent or bunched at the tip which is critical. Flaking of the coating would cause the catheter to
lose antimicrobial properties . This coating would require additional work to upscale to mass
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manufacturing levels when compared to the process of manufacturing uncoated catheters . Based
on the antimicrobial and mechanical success of this coating the team recommend the dip and
aerosolized with chlorhexidine coated catheter as the final product.

9. Recommendations for future work
Though the design of an antimicrobial Foley catheter was successful, there are many
recommendations for future work. Testing with biological fluids such as urine is important to
determine if there is any effect on the coating . It would also be important to compare the
antimicrobial and mechanical results of the final product with those of silver-coated catheters. A
cost analysis comparing the two products would also be beneficial to determine if the synthetic
spider silk coated catheter would be successful in the current market.
An additional test for surface fouling due to the adsorption of proteins such as fibrinogen should
also be performed. Fibrinogen is involved in blood coagulation which is a concern during
catheter use . Additionally, cytotoxicity assays should be completed to determine host cell
response to the presence of the coated catheters.
There are several changes that could be made to the coating protocols outlined in this design
report . Inner surface catheter coatings were examined but were not successful. However,
industry leaders remain interested in inner coatings of catheters . Therefore , new methods could
be developed based on the design completed in this project to successfully coat the inside of
urinary catheters . The effect of nanoparticles on antimicrobial properties when included in the
synthetic spider silk solutions before coating could be investigated as well.
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Reflection
My senior capstone project was the biggest project that I have worked on during my time as an
undergraduate student at USU. Not only was it the biggest project, but the most difficult and
time consuming as well. The project started with a concept that was introduced in our senior
design class at the beginning of the year and ended with a synthetic spider silk coated urinary
catheter that was created by me and six of my fellow biological engineering students .
The project started with a lot of brainstorming and literature review . We had an idea of what we
wanted the product to be but we did not have knowledge of the catheter industry and the
products that already exist. A previous group from Dr . Lewis' lab preformed research on
synthetic spider silk coatings on intravenous catheters (IV) . We sought to expand their research
and apply it to our urinary catheters.
We had to optimize coating protocols before we could start any of the coatings . The spray, dip,
and spray and dip methods were used previously for IV coatings. The general methods were the
same but we had to make slight modifications for urinary catheters . The previous group also
expressed interest in trying an aerosolized coating method with the use of a nebulizer but were
unable to coat their IV catheters . We included the aerosolized method and also developed the
dip and aerosolized method . Both methods required new coating protocols that were developed
by the team . Once all of the methods were optimized we were able to coat all the catheters and
start antimicrobial and mechanical testing .
This project required that we use skills that we have learned throughout our education at USU. It
was amazing to see things that we had learned be applied in a practical way . Antimicrobial
testing was completed by performing zone of inhibition testing which is something we learned
about and practiced in our required microbiology lab . The mechanical testing we performed
with the MTS Instron required use of an instrument that we 've been taught to use many times by
engineering professors over the last four years . The bend/bunch testing that we did required a
JD printed part that was made with SolidWorks which is a program that a few ofus learned in an
engineering graphics class . The statistics that we used to evaluate our final product were taught
to us in our statistics class . My proudest moment was at the end of the project when I created the
poster that we used to present our final product. l have worked in Dr . Benninghoff' s research lab
on campus for almost three years and have had many presentation opportunities . I have learned
how to make research posters under the guidance of both Dr. Benninghoff and Ph .D student
Sumira Phatak. Creating the poster was probably the least stressful part of this design project
because of all of my experience . When I first started working in Dr. Benninghoff' s lab I was
terrified of presenting because I didn't know how to make a poster and I didn't like public
speaking . Presentations are now my favorite part of a research project because I enjoy getting
the opportunity to talk to others about something that I am passionate about. This project has
shown me how well all of my research and education opportunities at USU have prepared me for
my future . I am very grateful for all of the professors and fellow classmates who have helped me
along the way.

74

We had mentors to help us through this design process but both Dr. Taylor and Dr . Lewis
maintained a hands-off approach . They were very helpful and always willing to offer advice but
they left us to brainstorm and solve problems as they occurred . I really appreciated that they
wanted us to do the work on our own because when I find a job after I graduate I will be
expected to accomplish tasks on my own. I was treated like a professional which was very
motivating because I wanted to prove that I am a self-sufficient engineer.
I learned a lot during this capstone design project about myself and the people that I worked
with . This past year has been extremely stressful and , although I' ve learned how to successfully
complete such a big project , I am glad to be finished and I'm proud of the work I've done . There
are many lesson s I've learned and I want to share them with anyone working on a capstone
project in the future .
1. Communication is key - My design team had a total of seven members and I learned very
quickly that it is almost impossible for everyone to be on the same page . One of my biggest
regrets is that we did not settle on communication expectations at the beginning of the project
and our team dynamic suffered greatly because of it. Find a form of communication that works
for everyone . We tried text messages , emails , and messaging apps but the only thing that
seemed to work was a phone call when we needed to contact each othe r. Make sure that
everyone on the team has the contact information for everyone in the group. I found out almost
six months into the project that one of my team members did not have any of my contact
information so he was not receiving any of the updates that I sent out. Team members are able to
avoid duties that they don 't want to do if they don ' t have constant communication with the rest
of the team. It is important to keep each other accountable and let others know deadlines are
approaching .
2. Don ' t be afraid to lead - When we first started our design project I thought we would all be
able to share duties and get things done in a timely manner. Unfortunately , that is not always the
case . Everyone has a different schedule and meeting times might not always include all of the
team members . This means that leaders are necessary in order to make sure that tasks get done .
I was already good friends with some of my design team and thought of them as my equal so I
felt very uncomfortable handing out assignments . Howeve r, the project will not be finished if
everybody avoids the leadership role . I recommending rotating the leadership position so that
everyone gets a chance to experience the expectations and the stress does not fall solely upon one
person .
3. Start early - I was warned about time management by last years ' senior design teams but I
don 't think our team took it very seriously . I hope that by passing on this advice maybe one year
will get it right. We started working on our project in about March of 2017 and the final project
was due December 201 7. That means that we had almos t nine months to work on our project.
This may seem like a lot oftime but with the addition of classes and other extra-curricular
activities during the school year time will fly by . Make concrete deadlines and stick to them.
Communicate with each other when there are reasons that those deadlines are unable to be met.
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4. Ask questions - This project was difficult because it was a student-run project. Our design
professor treated us like working engineers and expected us to finish the project on our own. l
have taken many design classe s over the last four years but there is still so much I can learn
about both design and engineering . This can make the project seem very intimidating because
there are so many unknown problems that you will have to find solutions to. I learned very
quickly to ask for help when I needed it. If there is an instrument or procedure that you are not
familiar with ask someone who does . Your professors have much more experience than you do
and they are alwa ys willing to offer advice . If you are working on your project in a research lab
there are always other undergraduate , graduate, and post-doctoral researchers around . They are a
great resource especially if you are not familiar with the lab you are workjng in. Your team
members are also an important resource . Everyone has different interests and backgrounds and
someone on your team might have more experience with certain things .
5. Take chances - Our final product was a result of a conversation between me and a few of my
teammates . We were all working on different aspects of the project and thought it would be a
great idea to combine our ideas . It was not one of our original coating methods and we came up
with the idea almost half-way through our project. Inspiration can strike at any point in your
project. Don ' t discount an idea because it doesn 't fit into your timeline or come at the
beginning of your brainstorming process Be open to trying new things .
Capstone projects are a great way to spend time on something that you are passionate about. I
hope that I have offered insight into what the process is like and have provided helpful advice .
Every project is different and you will run into problems along the way . But , if you work hard,
the final project will be something that you are unbelievably proud of That is the best feeling in
the world .
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